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ABSTRACT 
Oleh Krupa: Imaging Genetic Influences on Brain Structure at Cellular Resolution  
(Under the direction of Jason L. Stein) 
 
Recent genome-wide association studies (GWAS) have uncovered hundreds of genetic loci 
influencing inter-individual differences in human brain structure using in vivo 3D imaging modalities 
such as MRI. Distinct structural deficits have also been identified in individuals with neuropsychiatric 
disorders. However, MRI cannot resolve the cellular components that drive gross brain structure changes, 
which limits our understanding of the underlying cellular mechanisms that lead to disease risk. Tissue 
clearing methods are a relatively new class of techniques that make whole tissues transparent, allowing 
them to be visualized in 3D using fluorescence microscopy without the need for physical sectioning. After 
labeling with cell-type specific fluorescent markers, intact 3D brain samples can be rapidly imaged using 
light-sheet microscopy at cellular resolution. However, significant computational challenges remain in 
analyzing these multi-terabyte datasets, limiting the overall adoption of tissue clearing methods by the 
scientific community. In my dissertation work, I describe a computational package called NuMorph that I 
developed to perform end-to-end processing of tissue cleared images with the ability to quantify all cell 
nuclei within the mouse cortex. I then describe how NuMorph was used to investigate two extremely 
distinct mouse models: a Topoisomerase 1 (Top1) conditional knockout model with severe 
neurodegenerative deficits and a Neurofibromin 1 (Nf1) conditional knockout model with a more subtle 
brain overgrowth phenotype. In each model, unique, cell-type specific differences in cellular composition 
were uncovered across cortical regions that ultimately contributed to gross morphological changes and 
disease etiology. In addition to NuMorph, I also describe Segmentor, a new software package used to 
quickly generate annotation data to improve cell segmentation accuracy using deep learning algorithms. 
Finally, I provide an example of how common genetic variation near the gene FOXO3 regulates neural 
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progenitor proliferation that impacts cortical surface area and how the structural phenotypes caused by 
molecular perturbation of this gene can be interrogated by tissue clearing and 3D imaging of human brain 
organoids. In summary, this work demonstrates the unique advantages of tissue clearing methods over 
classical imaging approaches, and how next-generation image analysis tools can catalyze novel 
neurobiological discoveries.  
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CHAPTER 1: INTRODUCTION 
1.1 Genetic variation affecting brain structure and risk for neuropsychiatric illness. 
In the past decades, genetic studies have uncovered genome-wide significant loci influencing 
complex traits related to the brain (1, 2). These traits include measurements of brain structure and 
function acquired by magnetic resonance imaging (MRI) (3, 4), risk for various diseases of the brain such 
as schizophrenia (SCZ) (5), bipolar disorder (BD) (6), autism (ASD) (7), and major depressive disorder 
(MDD) (8), as well as cognitive traits such as intelligence (IQ) (9) and educational attainment (EA) (10). 
The heritability of brain-related traits can be explained by both common variation and rare genetic 
mutations.  Common variants, or variants with allele frequencies >1% in a general population, typically 
have small effect sizes individually, but cumulatively can make up a significant proportion of genetic risk 
(11). Both twin and large scale genomic studies using single nucleotide polymorphism (SNP) arrays have 
identified hundreds of loci that partially explain the heritability for complex, polygenic disorders, such as 
SCZ, MDD, and BD (12). Meta-analyses across multiple disorders have also revealed substantial genetic 
correlation between clinically distinct diagnoses, indicating a partially shared genetic structure (13). 
Significant genetic overlap has also been identified between disorders and brain structure traits, based on 
common variant effects (4).  
 
In contrast, rare variants, or variants with allele frequencies <1%, occur less frequently in a 
population but can have highly penetrant effects that can lead to disease risk. For example, loss-of-
function mutations in CHD8 and DYRK1A, have been observed in patients with ASD and intellectual 
disability and almost never in controls (14, 15). While most individuals with ASD do not have a known 
causal rare mutation (16, 17), profiling these variants can be used to characterize genetically defined 
syndromes (18, 19). These subtypes can exhibit specific alterations in brain structure, such as brain 
 2 
overgrowth (20) or microcephaly (21, 22), which provide clues into the underlying biology behind 
idiopathic disease risk. As the cost for genetic sequencing continues to fall, the ability to profile even 
larger, genetically diverse populations, both at the rare and common variant level, will enable us to take a 
deeper look into the genetic architecture of neuropsychiatric disorders and their impacts on brain structure 
and function in the coming years.  
 
1.2 Biological processes involved in cortical development  
The human cortex is the outermost layer of the brain that is commonly associated with cognitive 
ability (23). Recent profiling of cortical surface area (SA) and thickness (TH) in 51,665 individuals 
identified genetic associations with interindividual differences in cortical structure. Interestingly, genetic 
effects on cortical structure were partially shared with those variants associated with general cognitive 
function as well as risk for diseases such as Parkinson's disease, depression, and ADHD (4), 
demonstrating that genetic changes on cortical structure also are shared with those on behavior. Cortical 
structure is shaped in large part during the neurogenic stage of brain development, which primarily occurs 
at 7 to 27 postconceptional weeks in humans (24).  The fetal cortex can be divided into multiple cortical 
laminae, each enriched with specific neuronal or neural progenitor cell types. The lower laminae are 
composed of progenitor cell-types, such as radial glia and intermediate progenitor cells, that reside in the 
ventricular and subventricular zones. These progenitor cell-types undergo symmetric and asymmetric cell 
divisions expanding the progenitor cell pool or producing newborn neurons. Neurons then migrate along 
radial processes into the upper cortical laminae and further differentiate into more mature neuronal 
subtypes, thereby generating the six layer organization that comprises the adult cortex (25). Immediately 
following neurogenesis, progenitor cells begin differentiating into glial cell-types, such as astrocytes and 
oligodendrocytes, that facilitate myelination and formation of neural circuits that further shape overall 
cortical structure.  
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Cortical SA and TH are thought to be highly influenced by the balance of symmetric and 
asymmetric divisions of neural progenitor cells that drive cortical expansion during fetal brain 
development. The radial unit hypothesis asserts that cortical SA is determined by the number of 
symmetric, proliferative divisions of cortical progenitors whereas cortical TH is driven by the number of 
asymmetric, neurogenic divisions (Figure 1) (26). Modulation of these processes can not only influence 
the total number of neurons that are produced, but also the differentiation of these neurons into specific 
subtypes (27). Furthermore, transcriptional studies have identified significant spatial differences in gene 
expression, which also coincide with differences in lamination organization across functionally distinct 
cortical regions (28–30). In summary, the precise spatiotemporal regulation of neuron production and 
cell-type specification is required for typical cortical development and neural circuit formation. 
Disruption of these processes may drive the underlying etiology of various disorders of the brain or 
modulate human behaviour within a “neurotypical” range. As an example, I show in Chapter 4 how 
common variation near the gene FOXO3 can modulate neural progenitor proliferation and also lead to 
behavioral phenotypes such as increased human intelligence. 
 
 
Figure 1. Effects of Neural Progenitor Proliferation on Cortical Structure According to the Radial 
Unit Hypothesis 
Radial glia in the ventricular zone undergo symmetric divisions to form additional radial units that expand 
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cortical surface area (right). Alternatively, these cells can undergo asymmetric divisions to produce 
intermediate progenitors and newly born neurons that drive cortical thickening (left). 
 
1.3 Alterations in cortical structure in disorders of the brain 
MRI is a powerful tool that provides the ability to measure the full 3 dimensional (3D) structure 
of the brain within living humans. Using MRI, neuroimaging studies have reported examples of brain 
structure abnormalities in psychiatric disorders, including structural changes in the cortex. For example, 
patients with schizophrenia have decreased cortical thickness in frontal and temporal lobes; a phenotype 
that also correlates with age of onset and symptom severity (31). Similarly, patients with bipolar disorder 
have reduced cortical thickness in frontal, temporal, and parietal regions (32). In contrast, patients with 
ASD exhibit increases in cortical surface during early infancy (33). Brain structural differences are 
typically much smaller for common idiopathic forms of diseases such as SCZ and ASD (34, 35) 
compared to rare genetic disorders, requiring larger sample sizes of individuals with idiopathic disorders 
to identify differences. However, certain rare genetic disorders have shown large, consistent effects on 
brain structure. For example, Bannayan–Riley–Ruvalcaba syndrome (BRRS) and Cowden Syndrome 
(CS) are caused by germline mutations in the gene PTEN and result in macrocephaly, or increased brain 
volume, within 94% of patients (36). On the other hand, primary microcephaly (MCPH) is a disorder 
characterized by a large decrease in brain volume and is caused by mutations in genes involved in cell 
division (37). As brain structure deficits for disorders such as MCPH can be detected at birth, it’s clear 
that neural proliferation and differentiation during fetal development are critical processes for determining 
brain shape (38). In this work, I profile the brain structural deficits caused by monogenic deletions in 
Top1 and Nf1.  
 
Topoisomerase I (TOP1) is an enzyme that relieves DNA supercoiling (39) and acts as a 
transcriptional regulator in neurons (40, 41). Depletion of Top1 or inhibition by treatment with 
topoisomerase inhibitors, results in reduced expression of long genes (>100kb) (40). Many of these long 
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genes are disproportionately expressed in neuronal cell-types within the brain (42) and are critical to 
synaptic function (43). Recently, a Top1 cKO mouse model was developed by our collaborator Dr. Mark 
Zylka where Top1 was specifically deleted in cortical excitatory neurons (44). This deletion resulted in 
severe neurodegeneration throughout the cortex where lower cortical layer neurons were 
disproportionately affected. However, these effects were only profiled in a single region within the 
somatosensory cortex. In this work, our goal was to measure the effects of Top1 deletion throughout the 
cortex to see if certain regions were more susceptible to degenerative phenotype.  
 
Neurofibromin I (NF1) is GTPase-activating protein that negatively regulates the RAS/MAPK 
pathway (45, 46). Mutations in NF1 lead to a genetic disorder Neurofibromatosis type 1 that is autosomal 
dominant and affects 1 in 3000 individuals (47). While the defining features of Neurofibromatosis type I 
are tumors of the nerve sheath called neurofibromas, other brain related manifestations such as cognitive 
impairment, ADHD, and ASD have also been linked to mutations in the NF1 gene (46, 47).  MRI 
imaging of patients diagnosed with Neurofibromatosis type 1 identified structural differences within the 
brain, including increases in cortical thickness within occipital regions and decreased thickness in frontal 
regions (48). To characterize this brain phenotype in greater detail, our collaborator Dr. Lei Xing 
generated an Nf1 mouse model where the Nf1 gene was deleted specifically within dorsal telencephalic 
progenitor cells. In this work, we used this Nf1 model to explore the cellular mechanisms that lead to 
changes in cortical structure as seen in patients with Neurofibromatosis type 1. 
 
While MRI provides a view of gross brain morphology, a fundamental limitation is that MRI does 
not have sufficient labeling or resolution to resolve the cells that are leading to differences in structure. 
For example, in patients with Neurofibromatosis type I, we cannot distinguish which cell-types are 
causing differences in cortical thickness from MRI imaging. In cases where there are no noticeable 
differences in gross brain structure, changes in cortical cytoarchitecture within specific brain regions may 
still contribute to disease pathology. Physical sectioning and immunohistochemical labeling of post-
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mortem tissues can be performed to identify these changes within individual slices. For example, 
stereological analysis of ASD post-mortem tissue discovered focal patches of abnormal laminar 
cytoarchitecture within prefrontal and temporal but not occipital cortex, with the largest abnormalities in 
layers IV and V (49). Other studies of ASD however, did not detect deficits in cortical lamination but 
found reduced neuron densities specifically within the fusiform gyrus (50). Some of these discrepancies 
may at least be partially attributed to the limitations of the classical 2D stereology. Physical sectioning is 
typically slow to do and is prone to distortions. Image reconstruction is also required to extract 3D 
information and, even then, the reconstructed region is usually only a small portion of the full cortical 
volume (49). Because of the heterogeneity of disorders such as ASD, there is a clear need to measure the 
cellular composition of entire cortical structures which cannot be done at high-throughput using 2D 
stereology of small tissue samples.  
 
1.4 Tissue clearing resolve the 3D cellular organization of intact brain tissues 
To gain the benefits of cellular resolution analysis while preserving the 3 dimensional structure of 
intact tissues, tissue clearing methods have been developed that render whole tissues transparent while 
preserving protein and nucleic acid content and localization. First mentioned over a century ago by 
anatomist Werner Spalteholz (51), they have undergone a recent resurgence due to the development and 
implementation of optical sectioning in modern fluorescence microscopy systems. Tissue clearing 
protocols work by removing lipids, pigments, and minerals using aqueous or solvent-based solutions with 
the goal of homogenizing refractive indexes (RI) (52–54). Immersing the processed sample in a RI-
matched medium minimizes light scattering, allowing structures deep within the tissue to be visualized 
and imaged using microscopy without the need for tissue sectioning. Hydrogel-based methods such as 
CLARITY (55, 56) and PACT (57) achieve lipid removal using a sodium dodecyl sulfate (SDS) detergent 
while crosslinking tissues with acrylamide monomers to preserve structure. Other hydrophilic clearing 
methods such as CUBIC (58, 59), use soluble chemical cocktails of polyhydric alcohols, detergents, and 
urea to achieve clearining. Organic solvent based methods include 3DISCO (60) and iDISCO (61) and 
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use a combination of tetrahydrofuran (THF), dichloromethane (DCM), and dibenzyl ether (DBE). 
Incorporating fluorescently tagged antibodies, oligomers, or molecular dyes during the clearing procedure 
allows for detection of various proteins and macromolecules of interest. An enhanced version of the 
iDISCO protocol, called iDISCO+ (62), demonstrated improvements in antibody penetration, the 
preservation of native tissue volume, and was used as the clearing method-of-choice in this work. Further 
modifications to clearing protocols can also induce tissue shrinkage for more rapid image acquisition (63) 
or tissue swelling to resolve subcellular structures beyond the diffraction limit (64, 65). While initially 
validated on mouse brain samples, clearing of other organs using these protocols has also been 
demonstrated, including whole body clearing of the adult mouse (57, 63) and whole human embryos in 
the first trimester of gestation (66).   
 
Microscopes capable of rapid, volumetric imaging are required to extract 3D information from 
cleared tissues. Recent modifications of point scanning systems such as confocal (67) and two photon 
(68) microscopes have increased the acquisition speed for high resolution volumetric imaging. However, 
the most commonly used approach for imaging cleared tissues is via light-sheet microscopy, which can 
resolve cellular and subcellular structures while even further optimizing acquisition rate. Light-sheet 
microscopes typically illuminate the sample from the side using a thin sheet of light, resulting in a 2-3 
orders of magnitude increase in imaging speed compared to traditional point scanning systems (56). 
Photobleaching is also greatly minimized as only the focal plane is illuminated with light. Generally, 
imaging speed of light-sheet microscopes are limited by the camera frame rate, which can be as high as 
several hundred million voxels per second for state-of-the-art sCMOS detectors (52). This can result in 
extremely large datasets at terabyte scale even for individual cleared samples (69). Additionally for 
imaging large samples, most detection objectives cannot fit the entire specimen within the field-of-view, 
which results in a trade-off between acquisition rate and resolution. Due to the design of conventional 
optics, maintaining a sufficiently thin sheet of light across the imaged area can also be challenging and 
may require solutions such as axial sweeping (70) or multi-view reconstruction (71, 72) to reach the target 
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resolution. Cumulatively these factors have important implications in the resulting image quality and 
acquisition throughput for volumetric imaging. Due to large image size and technical image artifacts, 
advanced computational tools are therefore needed to extract quantitative information from cleared tissue 
images.  
 
1.5 Computational pipelines for analyzing tissue cleared images 
While great strides have been made in the development of clearing protocols and design of rapid 
and sophisticated light-sheet imaging systems, significant challenges remain in the analysis and 
quantification of features within the imaging data. To detect cellular-level phenotypes within cleared 
brain images, a multi-step framework is required. In addition to important pre-processing steps, image 
analysis of cleared tissues consists of (1) mapping images to a reference atlas for structural annotation, (2) 
quantifying cells within specific brain regions, and (3) classifying cell-types based on co-localized protein 
marker labeling.  
 
Prior to analysis, cleared images normally go through several pre-processing steps in order to 
generate a fully assembled image. These steps include normalizing intensity variation, aligning multiple 
fluorescent channels, and stitching tiled images. Adjusting intensity can consist of applying flatfield 
correction to normalize variation in the field of view, as well as correcting variation across image tiles 
that can occur from photobleaching or other sources of fluorescence quenching during the course of long 
term imaging. As fluorescence channels may be captured using a single detector, proper alignment of 
multiple channels is not guaranteed. Therefore additional image registration may be necessary to ensure 
complete overlap between channels that are acquired sequentially. To achieve high resolution images of 
complete structures, stitching of multiple fields of view is required. There are several tools available with 
the capability to perform stitching of 3D light-sheet images (73, 74). However, it has been noted that 
these tools may not perform well when there are large inconsistencies in stage positioning within an 
image stack (75, 76).  
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Image registration calculates the anatomical correspondence between multiple whole brain 
images. Registration algorithms are typically used to annotate regions within acquired brain images 
through registration to an atlas (e.g. Allen Brain Atlas) (77) and/or measure subtle anatomical volumetric 
differences relative to a defined template. Typically image registration proceeds by estimating a series of 
rigid and nonlinear transformation parameters by optimizing a similarity metric (e.g. mutual intensity 
information) between image pairs. Although accurate pairwise registration of stereotypical brains can be 
achieved using this approach, more advanced registration algorithms or manual intervention may be 
required for aligning brains with severe structural deficits.  
 
Cell segmentation consists of assigning each pixel or voxel in an image to a unique cell. The most 
commonly segmented features within an image are the cell nucleus and cell body. Nuclear segmentation 
is typically an easier task as nuclei pixels are more sparse and provides the approximate location of each 
cell within an image for cell counting. However, many of the current segmentation methods perform 
thresholding of nuclear staining intensities and select nuclei of a predefined size and blob-like shape (62, 
69, 78). Although the computational cost of this approach is low, it inaccurately assumes that the size and 
shape of nuclei are similar across cell-types. For example, endothelial cell nuclei are smaller and more 
oblong compared to neuronal nuclei, which are larger and more spherical. Applying thresholding-based 
methods to images with high labeling density decreases detection accuracy leading to inexact cell 
counting results. More recent machine learning algorithms that employ convolutional neural networks 
have achieved impressive results setting new benchmarks for segmentation accuracy and generalizability 
(79, 80). However, there are few, if any, deep learning frameworks that are capable of 3D cell 
segmentation of large image datasets acquired after tissue clearing. Furthermore, to achieve accurate 
segmentation using deep learning models, a large amount of manual annotation data is required for 
network training to fully generalize across different features present within images. This data can be 
difficult to acquire, particularly for 3D image data.  
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Cell classification is the process of assigning cells or individual voxels within an image to 
specific classes based on labeling in multiple image channels. While inherently similar to cell 
segmentation, cell classification does not necessarily survey each voxel within an image but can use cell 
positions calculated through cell segmentation to assign predicted classes. Simple thresholding on image 
intensity can again be used for classification if molecular labeling is robust. However, ignoring cellular 
features such as size and shape may lead to misclassification and there is potential bias in determining an 
appropriate threshold for a given cellular marker. Supervised learning methods, such as random forest 
classifiers, have been used for detecting and classifying marked cell populations within tissue cleared 
images with greater accuracy (81). However, these populations are only subsets of all cells present within 
a tissue, making this an easier task to perform.  
 
The computational frameworks currently available for quantifying cells within cleared brain 
images include tools such as ClearMap (62) and CUBIC informatics (69). As mentioned previously, these 
tools have been used for quantifying mostly sparse cell populations or within images at high spatial 
resolution acquired by custom light-sheet systems. Furthermore, these tools lack certain image processing 
capabilities that are required for analyzing large, multi-channel datasets. To meet the challenges of 
analyzing tissue cleared images, I developed a computational package called NuMorph that performs all 
preprocessing and analysis steps required for cellular quantification within the adult mouse cortex, which 
is discussed in Chapter 2 . Furthermore in Chapter 3, I introduce Segmentor, an additional software tool 
that enables rapid annotation of 3D image data for training more advanced deep learning frameworks.  
 
1.6 Modeling cellular phenotypes present during cortical development 
Much of our current knowledge on the cellular and molecular processes involved brain 
development stems from the use of animal models. Through genetic engineering, individual genes of 
interest can be activated, deleted, or molecularly tagged in a cell-type specific manner to tease out causal 
pathways using a wild-type/knockout experimental design. Traditionally some of the most popular model 
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organisms used for neuroscience research include rodents (82), zebrafish (83), roundworms (84), and the 
common fruit fly (85). Animal models have several key advantages over in vitro cell culture systems as 
tools for modeling brain development. The most obvious advantage is that the development of the 
complete central nervous system can proceed within an intact mammalian organism, preserving key 
physiological interactions with other organ systems. Developmental trajectories of animal models are also 
much faster than human models and the postnatal stages of brain maturation can be easily interrogated. 
Furthermore, animal models provide the opportunity to study behavioral phenotypes and how they are 
affected by specific genetic or environmental perturbation. The activity of individual neurons and neural 
networks can also be visualized and mapped to the execution of specific behavioral tasks. While these 
factors make animal models an attractive option for studying the brain, the fundamental limitation of 
animal models is that they are not human and therefore cannot reproduce the precise genetic architecture 
as a brain disorder patient. However, I show in Chapter 2 using a mouse model of Neurofibromatosis 
Type 1 that certain structural phenotypes, such as differences in cortical thickness, can still be 
recapitulated.  
 
In vitro cell culture models using human derived cells are an important alternative to animal 
models for scientific research. Neural progenitor cells (NPCs) can be derived directly from primary 
human tissues or by differentiating induced pluripotent stem cells (iPSCs). At the progenitor stage, NPCs 
can be used to model proliferation and differentiation involved in human cortical development as they 
have similar gene expression patterns and developmental trajectories (86). Cell culture assays can be 
designed to screen for various cellular and molecular phenotypes at much higher throughput compared to 
animal models. Recent developments in human brain organoid systems have also recapitulated the 
process of cortical lamination, providing an opportunity to analyze cortical structure at cellular resolution 
in a dish. However, perhaps the greatest advantage of cell culture models is the ability to reprogram cells 
directly from patients diagnosed with psychiatric disorders. By differentiating stem cells from these 
patients, we can recreate the precise molecular events that lead to disease risk, which would otherwise be 
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inaccessible. Overall, cell culture models provide a means for studying the effects of human-specific 
genetic variation on cortical development and associated complex traits. In Chapter 4, I use NPCs to 
examine the neurobiological mechanisms associated with variation at the FOXO3 locus. In Chapter 5, I 
demonstrate how tissue clearing approaches can be applied to study developmental pathways using 
animal and brain organoids as model systems.  
 
To study the effects of genetic variation on brain structure phenotypes at the cellular level, in 
Chapter 2 I developed NuMorph to perform quantitative analysis of cell-types within 3D brain tissues. 
Here I mapped the effects of single gene deletions on cortical cell-type distribution across cortical regions 
within the Top1 cKO and Nf1 cKO mouse models. In Chapter 4, I show how cellular mechanisms present 
during human cortical development can lead to differences in adult brain structure and in Chapter 5 I 
show how these developmental brain structure phenotypes can be assayed using human model systems. 
While at this stage, accurate cell quantification of embryonic tissues using NuMorph is not possible, in 
Chapter 3 I introduce Segmentor as a tool to rapidly acquire manual annotation data to train more 
advanced machine learning algorithms for cell segmentation.   
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CHAPTER 2: NUMORPH TOOLS FOR CELLULAR PHENOTYPING OF TISSUE CLEARED 
WHOLE BRAIN IMAGES 
2.1 Introduction  
The mammalian cortex is composed of a diverse assembly of cell-types organized into complex 
networks, which function together to enable complex behaviors (87–89). Disruption of cortical 
cytoarchitecture, either by genetic or environmental perturbation, can lead to altered brain function and 
create risk for neuropsychiatric disorders (49, 90). A common approach for studying the mechanisms by 
which genetic variation increases risk for neuropsychiatric disorders is through the use of genetically 
modified animal models in a WT/KO experimental design. In order to observe the causal effects of 
disorder relevant genes on structure-function relationships, genetic tools can be applied to activate or 
silence genes in specific cell-types (91) followed by imaging cellular organization through fluorescence 
microscopy.  One critical goal in such experiments is to determine if the number of cells of a given type 
are altered by these genetic risk factors throughout different brain structures. However, a common 
limitation in imaging experiments done at cellular resolution is that they are restricted to  anatomical 
regions of interest by physical sectioning which prevents the detection of region-specific effects. This 
becomes a particular issue for the cortex, one of the largest structures in the brain (77), where 
heterogeneity between cortical areas is often unmeasured by standard methods. 
 
In order to image the entire brain without physical sectioning, tissue clearing methods render 
biological specimens transparent while preserving their 3 dimensional structure. Cleared tissues can then 
be rapidly imaged using light-sheet microscopy as plane illumination improves acquisition rates by 2-3 
orders of magnitude compared to point scanning systems while also limiting the effects of photobleaching 
(52, 92). Great strides have been made in the development of clearing protocols that are compatible with 
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immunolabeling and the design of complementary sophisticated imaging systems (69, 78, 93, 94). Yet 
challenges still remain in expanding the accessibility of these technologies to research labs for 
quantitative analysis at cellular resolution.  
 
For example, many of the current imaging protocols for whole brain profiling require custom 
light sheet systems to image tissues at cellular resolution (56, 69, 95–97). These systems are therefore 
inaccessible to those lacking the expertise or resources required to assemble the necessary microscope 
components. Expanding tissues during the clearing process is a potential workaround that can increase the 
effective spatial resolution allowing for interrogation of subcellular structures without the need for custom 
imaging solutions (64, 76, 98, 99). However, expanded tissues can fall outside of the working distance of 
conventional microscope objectives, require prolonged imaging times, and significantly larger data 
storage resources. Therefore, computational tools designed for conventional light sheet microscope users 
are needed to compare cell counts in a WT/KO design. 
 
With over 100 million cells in a mouse brain and image sizes of tissue cleared brain approaching 
terabytes, advanced image analysis tools are needed to achieve accurate cell quantification. Current 
segmentation methods for tissue cleared brain images apply a threshold for nuclear staining intensity and 
filter objects with a predefined shape, size, and/or density (62, 69, 100). However, variations in cell size, 
image contrast, and labeling intensity can all lead to inaccurate counts. In addition, whole brain images 
are typically registered to a standard reference, such as the Allen Reference Atlas (ARA), to assign cell 
locations to their corresponding structural annotations. Thus far, image registration has been performed 
mostly on stereotypical mice and has not been designed for mouse models with significant changes in 
gross morphology. With these limitations, the computational tools currently available have not been fully 
adopted for studying cellular organization in mouse models.  
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To address these issues, we developed a group of image analysis tools called NuMorph (Nuclear-
Based Morphometry) (available here: https://bitbucket.org/steinlabunc/numorph/) for end-to-end 
processing to perform cell-type quantification within the mouse cortex after tissue clearing and imaging 
by a conventional light-sheet microscope. To demonstrate the effectiveness of the tool, we first applied 
and evaluated NuMorph to quantify structural changes in a mouse model with large differences in cortical 
structure, a topoisomerase I (Top1) conditional knockout (Top1 cKO) mouse model that exhibits clear 
reductions in both cortical size and specific cell types (44). We then apply NuMorph to investigate a 
neurofibromin I (Nf1) conditional knockout (Nf1 cKO) model, a gene harboring mutations in individuals 
with Neurofibromitosis type I. This disorder often results in cognitive impairment, attention-
deficit/hyperactivity disorder (ADHD), and autism spectrum disorder (ASD) (47). Our results reveal 
unique genetically influenced cell-type and structural changes in each mouse model, demonstrate the 
broad applicability of our analysis tools for studying both severe and subtle brain structure phenotypes in 
combination with tissue clearing methods, and present an alternative to 2D stereology for cellular 
quantification that does not rely on representative sampling.    
 
2.2 Results 
iDISCO+ Reveals Neuronal Cell-type Deficits in the Top1 cKO Cortex 
A previous study demonstrated that deletion of Top1 in postmitotic excitatory neurons within the 
cortex and hippocampus results in massive neurodegeneration in these structures by postnatal day 15 
(P15) (44). Interestingly, while all cortical layers were affected by Top1 deletion, the lower cortical layers 
(Layers 5-6) showed a noticeably greater reduction in thickness and cell count compared to the upper 
cortical layers (Layers 2-4) (44). These observations however were limited to the somatosensory cortex, 
which itself is a large structure that can be further decomposed into multiple functional regions. To 
evaluate the effects of Top1 deletion on excitatory neuron cell-types throughout all cortical structures, we 
performed iDISCO+ (62) to clear and image the Top1 cKO (Neurod6Cre/+::Top1fl/fl) mouse. We chose to 
use iDISCO+ among other tissue clearing techniques due to its demonstrated compatibility with antibody 
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labeling, minimal tissue expansion or shrinkage, and simplified protocol (62). To go beyond qualitative 
evaluation, we proceeded to develop cell detection and image registration tools that could accurately 
quantify the number of upper layer and lower layer neurons in each cortical region in Top1 cKO mice 
(Figure 2A). 
 
We processed one brain hemisphere from four wild-type (WT) and four Top1 cKO mice at P15 -  
when the Top1 cKO had displayed large, bilateral deficits in brain structure (44). We labeled layer-
specific cell-types using antibodies for Cux1 (upper layer neuron marker) and Ctip2 (lower layer neuron 
marker) in addition to staining all cell nuclei with TO-PRO-3 (TP3) during iDISCO+ processing. After 
clearing, samples were imaged using the Ultramicroscope II - one of the most widely used commercial 
light-sheet microscopes for imaging cleared tissues (58–60, 62, 63, 75, 101–103). The Top1 cKO 
hemispheres displayed a noticeable reduction in overall cortical volume (Figure 2B).  During light-sheet 
imaging, there is a well known trade off between optical resolution, particularly in the axial (z) 
dimension, and imaging speed. While the Ultramicroscope II features axial sweeping to maintain 
relatively even z resolution throughout the field of view (70), the additional mechanical movement of the 
light-sheet significantly reduces the imaging rate. After testing various imaging schemes, we imaged at 
1.21x1.21x4 (μm/voxel) resolution with a light-sheet thickness of 9 μm. The resulting images provided 
sufficient resolution to visually delineate cell nuclei in the cortex (Figure 2C) while limiting imaging time 
to 10-15 hours for all 3 channels in 1 WT hemisphere (~9 hours for Top1 cKO).  
 
Prolonged imaging of cleared tissue samples can induce several artifacts over the course of image 
acquisition. In particular, drift in the sample or aberrant microscope stage movement can cause 
misalignment between image tile positions within and between channels. These issues become more 
pronounced at higher optical resolution where slight variations can prevent colocalization of cell nuclei 
with their respective immunolabeled markers. To ensure correct alignment between channels, we applied 
a series of rigid and non-rigid registration steps using the Elastix toolbox (104) to map the Cux1 and 
 17 
Ctip2 channels onto the TO-PRO-3 channel without inducing non-specific local background warping 
(Figure 9). We also found that many of the commonly used programs for performing 3D image stitching 
(73, 74) did not accurately align adjacent tile stacks due to spurious stage movement, which has been 
noted by other groups (75). To ensure accurate image reconstruction, we applied a simplified iterative 2D 
stitching procedure that uses scale-invariant feature transforms (105) to produce continuous images 
without cell duplication along tile edges (Figure 10). Finally, differences in fluorescence intensity caused 
by light attenuation and photo bleaching during the course of imaging can result in uneven brightness 
between image tile positions. To ensure uniform signal across tiles, we measured the differences in image 
contrast in overlapping tile regions to estimate and correct for variations in signal intensity among tile 
stacks (Figure 9D). 
 
Completion of the preprocessing steps described above resulted in aligned, fully stitched 3 
channel images and datasets <1TB per sample (~400GB for WT and ~180GB for Top1 cKO). The Top1 
cKO hemispheres displayed clear reductions in thickness throughout the cortex (Figure 2D). While all 
cortical layers showed some amount of degeneration, Layer 5 and Layer 6 neurons seemed to be more 
severely depleted (Figure 2E) and we hypothesized that certain cortical areas may be differentially 
impacted as well. 
 
Point Correspondence Improves Image Registration for Structures with Large Morphological 
Differences 
Because of the significant differences in gross morphology within the Top1 cKO brain, image 
registration was not accurate using only intensity-based mutual information metrics (Figure 3A). To 
improve registration accuracy of the Top1 cKO brain, we manually selected up to 200 points at 
distinguishable structure landmarks in the Nissl stained ARA and their corresponding locations in the TO-
PRO-3 nuclei channel for each sample. Point locations were positioned primarily around the cortex as this 
was our region of interest (Figure 12A). Using Euclidean point distances as an additional metric during 
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the registration process significantly improved cortical annotation when compared to a manually 
delineated mask (Figure 3A). Increasing the number of points resulted in higher DICE similarity 
coefficient scores in Top1 cKO samples (Top1 cKO MMI, mean = 0.526, s.d. = 0.189; Top1 cKO MMI + 
200 Pts, mean = 0.890 s.d. = 0.013) indicating improvements in registration accuracy (Figures 3B and 
11B-D). These results show that point correspondence can be used to better register mouse models with 
large structural variation. 
 
Using the spatial deformation fields generated after image registration, we analyzed which areas 
in the Top1 cKO cortex exhibited the largest changes in volume relative to WT. While the cortex as a 
whole showed a large reduction in volume (mean = 80%, s.d. = 3.7%, p < 0.001), we observed slightly 
greater decreases in frontal regions, such as the orbitofrontal (ORB) and infralimibic (ILA) areas, as well 
as certain lateral regions near the temporal association area (TEa) (Figures 3B and 3C). This suggests that 
the neuronal cell-types within these structures may be more susceptible to degeneration upon Top1 
deletion. 
 
3D-Unet Accurately Quantifies Cell Nuclei in the Cortex 
3D cell segmentation of tissue cleared images can be difficult due to the density of cells in the 
brain, limits of imaging resolution, and overall data complexity. Here we implemented a deep learning 
model, based on a 3D version of the popular U-Net framework (3D-Unet) (106, 107), to accurately 
quantify the total number of cell nuclei marked by TO-PRO-3 staining within the cortex. We generated 
two sets of manually labeled nuclei: (1) For training, ~67,000 cortical nuclei were manually delineated 
from 256 training image patches (112x112x32 voxels/patch) of cortical nuclei at either high 
(0.75x0.75x2.5 μm/voxel) or low (1.21x1.21x4 μm/voxel) spatial resolutions. To increase manual 
delineation efficiency, we focused only on cell detection by delineating a 2D binary mask at the middle Z 
position to be used as a marker for each cell nucleus. (2) For evaluation, an independent set of ~3,500 
manually delineated nuclei were used where the full 3D extent of the nucleus was labeled in order to 
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determine accuracy of predicted centroid placement. Cell marker predictions within each 3D patch were 
then thresholded and analyzed for connected components to calculate final cell centroid positions (Figure 
3D).   
 
To evaluate cell detection accuracy, we compared precision and recall rates for detecting nuclei in 
the evaluation dataset using 3D-Unet and two previously published analysis tools for tissue cleared 
images with cell counting components: ClearMap and CUBIC Informatics (CUBIC). In our tests, 3D-
Unet achieved the highest precision and recall rates in both high and low resolution images when the full 
training datasets were used (Figures 3E and 3F). At low resolution, 3D-Unet achieved significantly lower 
error rates compared to the next best performing method (CUBIC) at higher resolution (p = 0.043, 
CUBIC 0.75/3D-Unet 1.21; p < 0.001, CUBIC 1.21/3D-Unet 1.21; p < 0.001, ClearMap 1.21/3D-Unet 
1.21; McNemar’s test). Using the trained 3D-Unet model, we counted 8.43(± 0.05)x106 cells in the P15 
WT cortex (Figure 3G), which was similar to previously published results in adult mice (98). This 
indicates that, with sufficient training, deep neural networks can compensate for a lack of imaging 
resolution and achieve accurate cell quantification.   
 
Lower Layer Neurons in the Frontal Cortex Are Preferentially Targeted by Top1 Deletion 
To quantify neuronal cell-types in WT and Top1 cKO cortexes, we developed a supervised 
Support Vector Machine (SVM) model to classify cell-types based on local intensity, shape, and 
annotation features. We found that a supervised approach, after training on 1,000 nuclei in each brain 
sample, achieved more accurate classification compared to an unsupervised mixture model approach 
(Figure 13). After removing outliers and summing across cortical structures, we counted 1.74(± 0.07)x106 
Ctip2+ and 1.94(± 0.05)x106 Cux1+ in WT compared to 0.30(± 0.08)x106 Ctip2+ and 0.73(± 0.11)x106 
Cux1+ in the Top1 cKO (Figures 4A and 4B). Overall, this constitutes an ~83% decrease in Ctip2+ cells 
and ~62% decrease in Cux1+ cells. When compared to previous results in 2D sections from 
somatosensory cortex (44), we saw a similar bias towards lower layer neuron degeneration (Cux1/Ctip2 = 
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1.97 in 3D SSp; 2.33 in 2D), however with a larger reduction in total neuron counts. While this can be 
partially attributed to differences in cell quantification methods, the increase in sampling depth from 
volumetric analyses can also uncover larger effects in total cell count compared to serial 2D analysis. 
 
Next, we compared differences in cell counts and density for 43 cortical areas defined by 
functional connectivity in the ARA (89) and the complete isocortex to see which regions were most 
affected by Top1 deletion. After correcting for multiple comparisons (FDR < 0.05), all but one of the 43 
structures showed a significant decrease in total TO-PRO-3 cell count indicating broad degeneration 
across all cortical areas in the Top1 cKO model (Figures 4C and 14E). Among neuronal cell-types, we 
identified 25 and 41 structures with significant decreases in Cux1+ and Ctip2+ cell counts, respectively. 
While many structures, including several areas in somatosensory cortex (SSp-n, SS-m, SSp-bfd), shared 
significant losses in both Cux1+ and Ctip2+ excitatory neurons, the largest reductions were seen in 
Ctip2+ cells localized in frontal areas, such as the prelimbic area (PL) and secondary motor area (MOs) 
not measured in previous work (44). We then calculated cell density by normalizing counts to registered 
structure volumes. Interestingly, the majority of structures show significant increases in TO-PRO-3+ cell 
density (Figure 14E), suggesting that, in addition to cell loss, degeneration of neuronal processes is also 
contributing to differences in cortical structure. Structures with the largest increases were again localized 
in frontal regions, such as the prelimbic (PL), infralimbic (ILA), and orbitofrontal (ORB) areas, as well as 
medial regions, such as the anterior cingulate areas (ACA). Decreases in cell number also resulted in 
greater reductions in cortical surface area compared to cortical thickness (Figure 14B-D). Taken together, 
these results show that, even in cases where genetic perturbation induces strong phenotypic effects such 
as in the Top1 cKO model, NuMorph can reveal more localized differences in cell-type number within 
specific brain regions.  
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Neurodegeneration is Spatially Correlated with Genes Differentially Expressed in Top1 cKO 
Previous evidence suggests that lower layer neurons, particularly those in L5, are most 
susceptible to degeneration as a result of reduced expression of long, neuronal genes in the Top1 cKO 
model (44). While the severe structural deficits in Top1 cKO precluded us from accurately quantifying L5 
neurons in individual cortical regions, we found that regions with large L5 volumes in the ARA saw the 
greatest reductions in total structure volume in Top1 cKO (Figure 5A). Furthermore, these regions also 
saw the largest increases in cell density (Figure 5B) suggesting local degeneration of neuronal processes. 
We then performed spatial correlations between regional cell count differences and gene expression using 
in-situ hybridization (ISH) data from Allen Mouse Brain Atlas (AMBA) (108). We tested whether the 
degree of Top1 cKO induced structural change among cortical regions was related to the expression of 
long genes (i.e. genes >100kb) within those regions, as Top1 is known to be a transcriptional regulator of 
long genes (40, 41). We found that in WT, regions with higher densities of Ctip2+ lower layer neurons 
were significantly associated with increased long gene expression (Figure 5C), providing further support 
that lower layer neurons express longer genes. Additionally, regions with larger reductions in cell 
numbers in Top1 cKO were correlated with increased long gene expression (Figure 5D). Interestingly, 
fold change in Ctip2+ count differences saw the lowest positive correlation, likely because significant 
lower layer degeneration had already occurred by P15, minimizing variation between individual cortical 
regions. Gene Ontology analysis using random-null ensembles to overcome gene-enrichment bias (109), 
identified 113 functional annotations associated with greater neuronal loss, including several processes 
involved in axon guidance and extension (Figure 14F). We then searched for spatial correlations with 
individual genes differentially expressed in the P7 Top1 cKO cortex as measured by scRNA-seq (44). 
Among the 125 differentially expressed genes in Top1 cKO that also contained ISH signatures in the 
AMBA, 5 were significantly correlated with relative difference in excitatory neuron count (Figure 4E). 
The most signficant gene, S100a10 (also known as p11), is predominantly expressed by L5a corticospinal 
motor neurons in the cortex (110, 111). Large reductions in Ctip2+ neurons in the Top1 cKO secondary 
motor area (MOs) and other frontal areas where S100a10 is highly expressed, suggest that changes in 
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S100a10 expression may increase susceptibility for L5 degeneration in these regions (Figures 5F and 5G). 
These results demonstrate how existing spatial gene expression resources can be leveraged with cleared 
tissue analysis to identify the specific genes, cell-types, and biological processes contributing to gene-
structure associations.  
 
Conditional Nf1 Deletion Induces a Brain Overgrowth Phenotype that Shares Similarities with 
Human MRI Results 
While the Top1 cKO model served as a suitable test case for applying NuMorph to study severe 
brain structure deficits, germline loss-of-function mutations in Top1 are highly deleterious and are 
extremely rare in humans (112). To further validate the utility of NuMorph for analyzing more subtle 
structural phenotypes in a disease-relevant animal model, we applied NuMorph to investigate Nf1 
knockout models of Neurofibromatosis type I (NF1).  We generated two novel Nf1 conditional knockout 
mouse models with one (Nf1fl/+;Emx1-Cre) or both (Nf1fl/fl;Emx1-Cre) copies of the Nf1 gene 
conditionally deleted in dorsal telencephalic progenitor cells by Emx1 promoter-driven Cre-
recombination (113). We chose Emx1:Cre mouse line because Cre recombinase activity can be detected 
as early as E10.5, 1 and 2 days earlier than Nestin:Cre (114) and hGFAP-Cre lines (115), respectively. In 
addition, the expression of Cre recombinase in Emx1:Cre mice is highly restricted to the dorsal 
telencephalic progenitor cells that allows us to  investigate the cortex-specific effect of Nf1 deletion. We 
found that bi-allelic Nf1 inactivation resulted in increased brain weight and decreased body weight 
compared to control and mono-allelic inactivation (Figure 15A-C). The increase in brain weight is evident 
as early as P0, suggesting a possible alteration in cortical development at the embryonic stage, a time 
window which is critical for both cortical neurogenesis and gliogenesis. We sought to systematically 
characterize this brain overgrowth phenotype using NuMorph. 
  
We performed tissue clearing and whole brain imaging of six control, six heterozygous knockout 
(Nf1fl/+;Emx1-Cre), and six homozygous knockout (Nf1fl/fl;Emx1-Cre) brain hemispheres in littermate 
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groups using the same Ctip2/Cux1 antibody panel as in the Top1 study. Nf1fl/fl;Emx1-Cre showed typical 
localization of Ctip2+ lower layer neurons and Cux1+ upper layer neurons (Figure 6A,B). Using 
NuMorph we also measured the average cortical thickness of 17 cortical regions and detected increased 
thickness in posterior regions such the visual (VIS), auditory (AUD), and posterior parietal association 
areas (PTLp) with slight cortical thinning in orbitofrontal (ORB) areas in the Nf1fl/fl;Emx1-Cre model 
(Figure 6C). These differences bear a strikingly similar pattern to human MRI findings where patients 
with neurofibromatosis type 1 were shown to have thicker occipital and thinner frontal cortices (48). 
Much of the increase in overall cortical thickness was driven by expansion of cortical layers 5 and 6 
(Figure 15D). To identify which cell-types were leading to increased cortical thickness in these regions, 
we quantified the number of ToPro3+ nuclei throughout the cortex and found a noticeable increase in 
overall cell count in Nf1fl/fl;Emx1-Cre (25% increase, p = 0.011) that was largely attributed to greater 
numbers of Ctip2-/Cux1- non-excitatory neuron cell-types (50% increase, p = 0.001)  (Figure 6D). No 
significant differences in global cortical cell count were observed in the heterozygous Nf1fl/+;Emx1-Cre 
model. 
 
Astrocytes and Oligodendrocytes Drive Increased Cortical Thickness in the Nf1fl/fl;Emx1-Cre 
Model 
We further investigated which specific cell-types comprised the Ctip2-/Cux1- class of cells that 
was driving cortical expansion in the Nf1fl/fl;Emx1-Cre model and how these effects varied across cortical 
regions. We found broad increases in the proportion of Ctip2-/Cux1- cells throughout the cortex (40/44 
structures FDR<0.05) with the greatest increases seen in posterior and medial areas such as the 
Retrosplenial, Auditory, and Visual cortices (Figure 7A). As expected, regions with higher Ctip2-/Cux1- 
cell numbers showed a significant positive correlation with cortical thickness (Figure 15E). To identify 
the specific cell-types within the Ctip2-/Cux1- class, we focused on non-neuronal cell-types differentiated 
from the Emx1-Cre expressing lineage: astrocytes and oligodendrocytes . Based on previously estimated 
cell type proportions within the adult mouse brain (116), regions with larger increases in Ctip2-/Cux1- 
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cell numbers in the Nf1fl/fl;Emx1-Cre model typically have a higher fraction of glial cell-types in the wild-
type cortex (Figure 7B), suggesting that the non-excitatory neuronal cells were glia. Furthermore, 
previous studies have shown inactivation of Nf1 results in aberrant proliferation of both astrocytes and 
oligodendrocytes (117–120). To confirm an expansion in glial cell numbers was present, we performed 
immunolabeling of P14 sections taken from the somatosensory cortex for Olig2 and GFAP, markers of 
oligodendrocytes and astrocytes, respectively, where we detected increased numbers of both Olig2+ and 
GFAP+ cells in this region (Figure 7C-F). Combined with our measurements of cortical thickness, these 
results suggest that increased production of glial cell-types may explain the cellular mechanism that leads 
to increased thickness of posterior cortical regions observed in NF1 patients.  
 
Nf1 Deletion Results in a Regionally-Specific Imbalance of Upper Layer and Lower Layer Neurons 
Finally, we looked at whether the proportion of Ctip2+ and/or Cux1+ excitatory neurons was 
altered across cortical regions following Nf1 deletion. While only a small number of regions were 
significant for changes in raw cell count for either Ctip2 or Cux1 in Nf1fl/fl;Emx1-Cre compared to 
control, we detected stronger effects when normalizing individual counts by total cell number or by 
volume (Figures 8A,B and 15G). In other words, alterations in cell-type distribution become more 
apparent when accounting for the increased rate of gliogenesis in the Nf1fl/fl;Emx1-Cre model. Across the 
entire cortex, we observed a significant reduction in the relative number of excitatory neurons following 
biallelic Nf1 deletion with a slightly greater reduction in the fractional proportion of Cux1+ neurons (35% 
decrease, p = 0.002, 19/44 structures FDR<0.05) compared to Ctip2+ neurons (24% decrease, p = 0.007, 
30/44 structures FDR<0.05). The organization of upper layer barrel fields was also disrupted in the 
Nf1fl/fl;Emx1-Cre model (Figure 15H), similar to previous work (121). In addition, we observed a strong 
inverse relationship in the change in Ctip2/Cux1 ratio where regions with a greater reductions in Cux1+ 
neurons saw lower reductions or increases in the number of Ctip2+ neurons, and vice versa. This negative 
correlation persists when comparing either total cell counts or cell density (Figures 8C and15G). These 
opposing findings across the cortex show the utility of a whole brain imaging approach, because slices 
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within specific regions may not be representative of all the effects. To further investigate whether upper 
layer neurogenesis is disrupted in the Nf1fl/fl;Emx1-Cre model, we performed EdU pulse labeling of E16.5 
mice and quantified their differentiated progeny within P14 brain sections of somatosensory cortex 
(Figure 8D). We saw a significant reduction of Satb2+ upper layer neurons co-labeled with EdU 
indicating decreased upper layer neurogenesis at E16.5. Considering the increase in gliogenesis seen in 
the Nf1fl/fl;Emx1-Cre mouse, this data suggests that Nf1 deletion may accelerate the brain’s developmental 
trajectory which can result in widely disparate effects on neuronal cell-type composition across cortical 
regions in the adult brain. 
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Figure 2. Cellular Resolution Analysis of Brain Structure Phenotypes for Tissue Cleared 3D Brain 
Images. 
A. Overview of tissue processing, imaging, and image analysis procedures. 
B. 3D rendering of cell nuclei in WT and Top1 cKO samples. 
C. Example of TO-PRO-3 (TP3) labeled nuclei within WT cortex captured at sufficient lateral (xy) and 
axial (xz) resolution for cell quantification. 
D. Optical sagittal sections of TO-PRO-3 nuclear staining and immunolabeling for cell-type specific 
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markers Ctip2 (lower layer neuron) and Cux1 (upper layer neuron) in WT and Top1 cKO samples. 
E. Zoomed in images of boxed cortical areas in D demonstrating channel alignment and showing the 
expected localization of upper and lower layer markers. 
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Figure 3. NuMorph Integrates Point Correspondence to Register Difficult Structures and 3D-Unet 
for Accurate Detection of Cortical Nuclei. 
A. Cortical masks from registered WT and Top1 cKO brain images (Magenta) compared with manual 
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labelled traces (Green). Mattes mutual information (MMI) was used as the primary registration metric 
with additional point correspondence to guide registration in the Top1 cKO case. 
B. Voxel-wise differences in cortical volumes between Top1 cKO and WT samples. 
C. Percent change in cortical region volumes in Top1 cKO samples compared to WT. Dashed line 
indicates average change across the entire cortex. Data represented as mean ± SEM. 
D. Description of 3D-Unet approach for detecting cell centroids (CC3D: 3D Connected Component 
Analysis). 
E-F. Comparison of cell detection precision (E) or recall (F) at the indicated xy resolutions (μm/pixel). 
Examples of misclassification instances contributing to false positive errors (E) or false negative errors 
(F) are shown above. Data represented as mean ± standard deviation. 
G. Cell centroids of WT cortical nuclei predicted by 3D-Unet. 
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Figure 4. Top1 Deletion Induces Broad Degeneration of Neuronal Cell-types Particularly in Frontal 
Regions. 
A-B. Point cloud display of Cux1+ (A) or Ctip2+ (B) cells within WT and Top1 cKO cortexes. 
C. Coronal slice visualizations displaying percent change in cell count (left hemisphere) and FDRadjusted 
p values (right hemisphere). Colored ARA annotations at corresponding positions displayed for 
reference. 
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Figure 5. Effects of Top1 Deletion Are Associated with Spatial Patterns of Gene Expression. 
A-B. Association between structure volume (A) and cell density (B) differences in Top1 cKO with L5 
volume as a fraction of total volume in the ARA. Data points shown for L5 associations. (R: Pearson 
correlation coefficient). 
C-D. Association between spatial gene expression and WT cell density (C) or negative fold change in cell 
count between Top1 cKO and WT (D). Spearman correlation coefficients, binned by gene length, for each 
gene’s expression across cortical regions were used for comparisons. Increased correlation indicates 
stronger association with cell loss in (D). TP3+ indicates all cells and ExNeun indicates excitatory 
neurons (i.e. Ctip2+ or Cux1+). Displaying mean ± SEM. 
E. Genes differentially expressed in Top1 cKO excitatory neurons significantly correlated with relative 
change in excitatory neuron count across cortical regions (Spearman; FDR < 0.05). 
F. ISH expression of S100a10 at P14 in the Allen Developing Mouse Brain Atlas (ADMBA) with the 
cortex outlined and a corresponding sagittal section of Top1 cKO. (MOs: secondary motor area). 
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G. Flattened isocortex displaying percent change in excitatory neuron counts (i.e. Ctip2+ or Cux1+) in 
Top1 cKO relative to WT. 
 
 
 
 
 
 
Figure 6. Nf1 Deletion Induces Cortical Thickening Driven by Increased Numbers of Non-
Excitatory Neuronal Cell-types. 
A. Optical sagittal sections of immunolabeled lower layer (Ctip2+) and upper layer (Cux1+) neurons in 
P14 Ctrl, Nf1fl/+;Emx1-Cre, and Nf1fl/fl;Emx1-Cre brain hemispheres. Zoomed in regions of boxed cortical 
areas near somatosensory cortex showing expected localization of upper and lower layer neurons. 
Average cortical thickness (TH) measurements indicated for full 3D somatosensory volumes. 
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B. 3D rendering of cell nuclei in Ctrl, Nf1fl/+;Emx1-Cre, and Nf1fl/fl;Emx1-Cre brain hemispheres. 
C. Flattened isocortex displaying percent change in cortical thickness in Nf1fl/fl;Emx1-Cre across 17 broad 
regions and the full isocortex (Iso) compared to Ctrl. Significant regions are bolded (FDR<0.05) and 
starred. Structure name abbreviations provided in Table S1. 
D. Total isocortex counts of each cell-type class measured across all Ctrl, Nf1fl/+;Emx1-Cre, and 
Nf1fl/fl;Emx1-Cre samples. 
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Figure 7. Nf1 Deletion Increases Production of Astrocytes and Oligodendrocytes Broadly 
Throughout the Cortex. 
A. Differences in relative proportion of non-excitatory neuronal cell-types (i.e. (Ctip2- & Cux1-
)/ToPro3+) across 43 cortical regions and the full isocortex (Iso) after Nf1 deletion. The top 15 regions 
sorted by binned p-value and fold change are shown (Nf1fl/fl;Emx1-Cre vs. Ctrl, FDR<0.05). Flattened 
isocortex displaying percent change in Nf1fl/fl;Emx1-Cre are shown on the right. Significant regions are 
bolded and starred (FDR<0.05). 
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B. Association between estimated astrocyte and oligodendrocytes proportion across regions in the 
wildtype cortex (Erö et al., 2018) and relative change in non-excitatory neuronal cell-types measured in 
Nf1fl/fl;Emx1-Cre. (R: Pearson correlation coefficient). 
C. Coronal slice visualization displaying percent change in cell count (left hemisphere) and FDR-adjusted 
p values (right hemisphere) as measured by 3D analysis.  
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Figure 8. Nf1 Deletion Alters Neuronal Cell-type Proportions in a Region-Specific Manner. 
A-B. Differences in relative proportion of Ctip2+ (A) and Cux1+ (B) cells across 43 cortical regions and 
the full isocortex after Nf1 deletion. The top 15 structures sorted by binned p-value and fold change are 
shown (Nf1fl/fl;Emx1-Cre vs. Ctrl, FDR<0.05). Flattened isocortex displaying percent change in 
Nf1fl/fl;Emx1-Cre are shown on the right. Significant regions are bolded and starred (FDR<0.05). 
C. Association between relative change in Ctip2+ and Cux1+ cell numbers across cortical regions in the 
Nf1fl/fl;Emx1-Cre. 
D. Representative 2D sections of 1mm cortical columns from P14 somatosensory cortex after EdU 
injection at E16.5 showing colocalization with SATB2 (callosal projection neurons) immunolabeling in 
upper layers. 
E. Quantification of EdU+/SATB2+ cells within 1mm cortical columns in D. (n=3-5 animals, mean ± 
SEM).
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Figure 9. Nonlinear Alignment and Intensity Adjustment of 3D Multichannel Images.  
A. Overview of alignment procedures.  
B. Example of channel misalignment after 2D registration by translation showing only part of the image 
aligning correctly. 
C. Same section as in B after the nonlinear alignment procedure. 
D. Top1 cKO sample images of Ctip2 labeling with (right) or without (left) adjusting intensities for tile 
positions and light-sheet width.  
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Figure 10. Iterative 2D Stitching of Multi-Tile Light Sheet Images.  
Sample results from 2D iterative stitching of WT mouse hemisphere compared with other dedicated 3D 
stitching software. Yellow lines indicate approximate stitching seams. 
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Figure 11. Image Landmark Selection for Points-Guided Image Registration.  
A. 1 mm thick sagittal maximum intensity projection displaying corresponding points positions in ARA, 
WT, and Top1 cKO brain hemispheres. 
B. DICE scores measuring cortical registration accuracy in WT and Top1 cKO samples based on the 
number of points used to guide registration. Measurements with no corresponding points were made using 
affine + b-spline registration without a points distance metric. Data represented as mean ± standard 
deviation. 
C. Coefficients of variation (CoV) of structure volumes for all cortical annotations in the ARA after 
registration with or without corresponding points. 
D. DICE scores and CoV metrics for indicated registration procedures. Data represented as mean (± 
standard deviation). CoV was calculated for individual ARA annotations (242 structures plotted in B) or 
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the full isocortex after registration. These compared with the CoV for the full cortex based on manual 
annotation. Bold value: Top1 MMI/Top1 MMI+ Pts, p < 0.001.  
 
 
 
 
Figure 12. 3D-Unet Training and Evaluation.  
A. 3D-Unet architecture adapted from (107).   
B. Approximate patch locations used for training the 3D-Unet nuclei detection model 
C. Example images of nuclei detection results. Cross symbols indicate centroids in the displayed z slice 
whereas points indicate centroids in slices directly above or below. Arrows indicate detection errors in the 
full 3D volume. 
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Figure 13. Cell-type Classification using Supervised SVM Classifier.  
A. Cell-type positions for upper and lower layer cortical neurons in a sagittal section for WT and Top1 
cKO after SVM classifications. 
B. Representative images of Ctip2+ and Cux1+ cell-type classification using SVM. Cross symbols 
indicate centroids in the displayed z slice whereas points indicate centroids in slices directly above or 
below.  
C. Classification accuracies using a trained SVM (supervised) classifier or by Gaussian Mixture Modeling 
(unsupervised). Accuracy is measured as the fraction of 1,000 cells in each sample with the correct 
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classification based on manual identification. SVM accuracies determined based on 5-fold cross-
validation. (***p < 0.001; McNemar test).  
D. Total counts for each cell-type classification in WT and Top1 cKO samples. 
E. Distributions of Ctip2+ and Cux1+ cells across cortical layers.   
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Figure 14. Structural and Molecular Associations with Cell Loss in the Top1 cKO Model.  
A. Heatmap displaying percent change in cortical cell count, volume, surface area, and thickness for each 
cortical region. 
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B-D. Correlation between total cell count difference and volume (B), surface area (C), and thickness (D) 
across cortical regions. 
E. Comparison of cell-type counts or densities between WT and Top1 cKO across cortical regions and the 
full isocortex. Displaying the top 15 structures (FDR < 0.05) binned by significance level and sorted by 
absolute difference in count or density within each bin. Data represented as mean ± standard deviation 
and plotted on log10 scale. Structure name abbreviations provided in Table S1.  
F. Gene ontology showing the top 25 most significant categories correlated with neuron loss in Top1 
cKO. Bolded categories contain at least 1 gene differentially expressed in Top1 cKO from scRNA-seq 
studies.  
 45 
 
Figure 15. Characterization of Nf1 cKO Models and Structural Associations with Cortical Cell-type 
Densities.  
A. Representative images of P14 brains from Ctrl, Nf1fl/+;Emx1-Cre, and Nf1fl/fl;Emx1-Cre mice. 
B-C. Brain and body weight measurements for Ctrl, Nf1fl/+;Emx1-Cre, and Nf1fl/fl;Emx1-Cre mice at 
multiple developmental time points. (n=29-45 animals for P0, 8-17 for P7, 49-84 for P14, 24-57 for P21 
and 12-22 for P56 samples, mean ± SEM).   
D. Quantification of cortical layer thickness in Nf1 models from 2D sections of somatosensory cortex. 
(n=6-9 animals, mean ± SEM) 
E.  Association between cortical thickness and relative change in Ctip2-/Cux1- cell counts in the 
Nf1fl/fl;Emx1-Cre model. (R: Pearson’s correlation coefficient). 
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F. Association between relative change in Cux1+ and Ctip2+ cell densities in the Nf1fl/fl;Emx1-Cre model. 
(R: Pearson’s correlation coefficient). 
G. Differences in cell densities of Ctip2+ and Cux1+ cells across 43 cortical regions and the full isocortex 
after Nf1 deletion. The top 15 structures sorted by binned p-value and fold change are shown 
(Nf1fl/fl;Emx1-Cre vs. Ctrl, FDR<0.05).  
H. Optical sections of cleared tissue autofluorescence showing disorganization of cortical barrel fields in 
Nf1fl/fl;Emx1-Cre and reduced Cux1+ neuron density in surrounding upper layer regions.  
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2.3 Discussion  
Tissue clearing methods provide a unique opportunity to explore the cellular organization of the 
entire 3 dimensional brain structure. However, the current computational tools for analyzing cell-types in 
tissue cleared images have either been applied to sparse cell populations where segmentation is less 
difficult (62, 81) or taken advantage of tissue expansion and custom-built light sheet systems to increase 
spatial resolution (69, 98). Here, we present NuMorph, a computational pipeline for processing and 
quantifying nuclei within structures of the adult mouse brain acquired by conventional light-sheet 
fluorescence microscopy. 
 
In the course of developing NuMorph and an appropriate imaging protocol, a large emphasis was 
placed on outlining a reasonable compromise between cell detection accuracy, imaging time, and 
computational resources. With the imaging parameters used to resolve cortical nuclei in this study, WT 
brain hemispheres required 3-6 hours of imaging per channel, while end-to-end processing and analysis 
using NuMorph required ~1 day with a GPU-equipped workstation. By training a 3D-Unet model on a 
diverse set of manually labeled nuclei from multiple imaging experiments, we were able to achieve 
effectively equivalent error rates at this resolution compared to 1.6x higher resolution (p = 0.91, 3D-Unet 
0.75/3D-Unet 1.21; McNemar’s test) that would have otherwise required significantly longer imaging 
times and expanded data size by ~4x for a whole hemisphere acquisition. We expect cell detection 
accuracy using the training dataset generated here will remain high for analyzing other brain regions with 
similar cell density, while supplementation with additional training data may be needed for denser 
structures such as the hippocampus. Furthermore, NuMorph provides additional features and flexibility 
such as (1) targeting analyses to specific structures after registration to avoid unnecessary computation 
time, (2) detecting cells directly by nuclear protein marker expression without DNA staining, and (3) 
classifying cell-types by cellular markers using either supervised or unsupervised methods. 
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Top1 is critical for maintaining genomic stability and regulating the expression of long genes 
important for neuronal function (122). Recent evidence suggests that many of these same long genes 
contribute to neuronal diversity and have the greatest expression in the forebrain (123). In the developing 
cortex, scRNA-seq studies found that L5 neurons had higher long gene expression compared to neurons 
from other cortical layers (124). In this study, we found that Top1 deletion preferentially targeted many 
frontal areas with high L5 thickness, larger numbers of Ctip2+ lower layer neurons, and greater long gene 
expression. These effects likely occur much earlier than the time point studied here as previous 
behavioural assays showed that severe motor deficits are present as early as P7 (44). Interestingly, 
inhibition of S100a10 - the gene most correlated with neuron loss - was recently shown to have a 
neuroprotective effect, delaying motor neuron loss in a mouse model amyotrophic lateral sclerosis (ALS) 
(125). Because Top1 deletion results in multiple stress factors that negatively impact cell health, 
additional studies will be needed to disambiguate which mechanisms ultimately lead to biased 
degeneration of certain neuronal subtypes across brain regions.  
 
Human MRI studies have detected gross cortical structural differences in individuals with 
neuropsychiatric disorders as compared to neurotypical controls (31). The cellular basis underlying these 
differences cannot be assessed with standard in vivo MRI, due to the low resolution and lack of cellular 
labels. Overall increases in brain size and regional variabilities in cortical thickness were previously 
detected in individuals with neurofibromatosis type 1 (48, 126). To explain the cellular basis underlying 
those findings, we used an approach complementary to MRI in humans, 3D cellular resolution imaging in 
a mouse model. Our Nf1 knockout model exhibited a broad expansion in glial cell numbers that drove 
cortical thickness increases particularly in posterior regions which reproduced human MRI measurements. 
Numerous studies have reported increased glial cell proliferation following Nf1 inactivation in both 
animal models and human iPSC lines (47, 117, 120, 127). However, this is the first study, to our 
knowledge, that performs a systematic comparison of areal differences upon Nf1 inactivation and how 
these relate to changes in brain structure seen in patients with NF1. We also found striking areal 
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differences in upper and lower layer neuron proportions upon Nf1 biallelic deletion in cortical neural 
progenitor cells early in development. This highlights the key advantages of 3D whole brain imaging over 
2D sectioning as stereological analysis may lead to highly variable results based on the anatomical 
location from which tissue is sampled. Further coupling of immediate early gene immunolabeling with 
cleared tissue analysis could reveal how specific structure-function relationships are altered at a cellular 
level in the Nf1 and similar models (62, 101, 128). 
 
While NuMorph has proven to be effective in analyzing moderately dense tissues such as the 
adult mouse cortex, the development of additional computational tools may be required to pursue more 
challenging experimental designs. For example, structures in the embryonic brain are typically of much 
higher cell density and vary in gross morphology across developmental time, making both cell 
quantification and image registration more difficult. In addition, segmentation and mapping of fine 
structures, such as neuronal processes, can be challenging with limited imaging resolution. Technological 
improvements in the next generation of light-sheet systems can ultimately allow for quantitative 
interrogation of subcellular structures at high throughput (129, 130). However, computational tools using 
deep neural networks have also proven to be effective in executing diverse segmentation tasks (75, 131–
133) or even enhancing image quality (134). Nevertheless, community-based efforts may be needed to 
generate sufficient annotation data for training deep learning models to accurately perform these tasks 
(135, 136). Together we hope these new imaging and computational tools will lead to greater adoption of 
tissue clearing methods for quantitative analyses, rather than qualitative visualizations, of how the entire 
brain structure is changed by genetic or environmental risk factors for neuropsychiatric disorders.  
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2.4 Methods 
Animals 
Top1 conditional knockout mice (Top1fl/fl;Neurod6-Cre, Top1 cKO) were bred by crossing 
Top1fl/fl mice (41) with the Neurod6-Cre mouse line (Jackson Laboratory) (137) as described previously 
(44). Cre-negative mice (Top1fl/fl) were used as controls (WT). Nf1 conditional knockout mice (Nf1fl/fl) 
were purchased from (Jackson Laboratory, Stock No: 017639) (127). Emx1-Cre mice were originally 
generated by Gorski et al. (113) and previously validated and maintained in the lab (138). Homozygous 
Nf1 cKO mice (Nf1fl/fl;Emx1-Cre) and heterozygous Nf1 cKO mice (Nf1fl/+;Emx1-Cre) were generated by 
breeding Nf1fl/+;Emx1-Cre mice with Nf1fl/fl or Nf1fl/+ mice. Cre-negative (Nf1fl/fl, Nf1fl/+, Nf1+/+) and 
Nf1+/+;Emx1-Cre mice were used as littermate controls. All animal procedures were approved by the 
University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee. Mice were 
maintained on a 12-hr dark/light cycle and housed at temperatures of 18-23°C, 40-60% humidity, and ad 
libitum food and water. Genomic DNA extracted from tail or ear samples was utilized for genotyping by 
PCR. Primers for gene amplification are as follows (listed 5’-3’): Top1-F: 
GAGTTTCAGGACAGCCAGGA, Top1-R: GGACCGGGAAAAGTCTAAGC; Cre-F (Neurod6-Cre): 
GATGGACATGTTCAGGGATCGCC, Cre-R (Neurod6-Cre): CTCCCATCAGTACGTGAGAT, Nf1-F: 
ACATGGAGGAGTCAGGATAGT, Nf1-R: GTTAAGAGCATCTGCTGCTCT, Cre-F (Emx1-Cre): 
GAACGCACTGATTTCGACCA and Cre-R (Emx1-Cre): GATCATCAGCTACACCAGAG. Male P15 
Top1 cKO and WT littermate controls were used for tissue clearing in the Top1 study. Male P14 
Nf1fl/fl;Emx1-Cre, Nf1fl/+;Emx1-Cre and Ctrl littermates were used for tissue clearing in the Nf1 study.  
 
Tissue Clearing & Immunolabeling 
Tissue clearing was performed on 4 WT and 4 Top1 cKO for the Top1 study and 6 Ctrl, 6 
Nf1fl/+;Emx1-Cre, and 6 Nf1fl/fl;Emx1-Cre for the NF1 study according to the iDISCO+ protocol (62). 
Genotyped samples were processed concurrently in littermate pairs/triplicates. Briefly, mice were fixed 
via transcardial perfusion using 4% paraformaldehyde and whole brain samples were dissected and cut 
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along the midline. As the effects of Top1 deletion on gross structure were bilateral upon visual inspection, 
only the left hemisphere was used in clearing experiments and analysis. Similarly, effects of Nf1 deletion 
were found to be bilateral based on 2D stereological analysis and therefore only the right hemisphere was 
used in the Nf1 study.  Investigators were blinded to genotype for the Nf1 study during tissue clearing and 
subsequent imaging and analysis. Large differences in overall brain size between Top1 cKO and WT 
prevented blinding in this model. Samples were then washed in phosphate-buffered-saline (PBS), 
dehydrated in a graded series of methanol (Fisher, A412SK), pretreated with 66% dichloromethane 
(Sigma- Aldrich, 270997)/methanol and 5% H2O2 (Sigma-Aldrich, H1009)/methanol, followed by 
rehydration, permeabilization (20% dimethyl-sulfoxide, Fisher, BP2311; 1.6% Triton X100, Sigma-
Aldrich, T8787; 23mg/mL Glycine, Sigma-Aldrich G7126), and blocking with 6% goat serum (Abcam, 
ab7481). Samples were then incubated with antibodies for Cux1 (Santa Cruz, sc-13024-Rb, 1:200) and 
Ctip2 (Abcam,  ab18465-Rt, 1:500) for 5 days at 37°C in PTwH buffer (PBS; 0.5% Tween-20, Fisher, 
BP337; 10mg/L Heparin, Sigma-Aldrich, H3393) . After 2 days of washing with PTwH, samples were 
then incubated with TO-PRO-3 (Thermo Fisher, T3605, 1:300), goat anti-rat Alexa Fluor 568 (Thermo 
Fisher, A11077, 1:200), and goat anti-rabbit Alexa Fluor 790 (Thermo Fisher, A11369, 1:50) for an 
additional 5 days at 37°C. Samples were then washed for 2 days with PTwH, dehydrated again using a 
graded methanol series, incubated in 66% dichloromethane/methanol for 3 hours, followed by a 30 
minute incubation in 100% dichloromethane before storing in a dibenzyl ether solution (RI = 1.56, 
Sigma-Aldrich, 108014) at RT. Tissue clearing and antibody labeling required 21 days to complete. 
 
Light-Sheet Imaging 
Imaging of cleared brain samples was performed using the Ultramicroscope II (LaVision Biotec) 
equipped with MVPLAPO 2X/0.5 NA objective (Olympus), sCMOS camera (Andor), and ImSpector 
control software. The zoom body was set to 2.5x magnification (yielding 1.21 μm/pixel) and a single light 
sheet was used with NA = ~0.08 (9 μm thickness/ 4 μm z-step) as this allowed for better resolution of cell 
nuclei compared to using multiple light sheets. Dynamic horizontal focusing using the contrast enhanced 
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setting in ImSpector was used to ensure axial resolution was maintained along the width of the image 
using the recommended number of steps depending on the laser wavelength. Samples were positioned 
sagittally with the cortex surface facing the single illuminating light-sheet (Figure 9D). This prevented 
excessive light scattering and shadowing from affecting the image quality in the cortical regions. 
Individual channels were acquired for tiled positions in a row-major order using 561nm (Ctip2), 647nm 
(ToPro), or 785nm (Cux1) laser lines. The 785nm channel was imaged first for the entire hemisphere. 
After refocusing the objective, the 561nm/647nm channels were then captured sequentially for each stack 
at a given tile position. Using these settings, mouse hemispheres were acquired using 3x3, 4x4, or 4x4 
tiling schemes depending on hemisphere size with 5-15% overlap. Typical imaging times ranged from 10 
to 15 hours for all 3 imaged channels. In the Nf1 study, tissue autofluorescence was additionally imaged 
within a single tile using a 488nm laser at 0.8x magnification (3.86 x 3.86 x 4μm/voxel; 0.015 light sheet 
NA, no horizontal focusing) for all samples.  
 
Computing Resources 
All data processing was performed locally on a Linux workstation running CentOS 7. The 
workstation was equipped with an Intel Xeon E5-2690 V4 2.6GHz 14-core processor, 8 x 64GB DDR4 
2400 LRDIMM memory, 4 x EVGA GeForce GTX 1080 Ti 11GB GPU, and 2 x 4TB Samsung EVO 860 
external SSDs. Hot swap bays were used to transfer data from the imaging computer to the analysis 
workstation. 
 
Image Preprocessing 
Image preprocessing consists of all the necessary steps to prepare acquired raw images for image 
registration and cell quantification. All preprocessing steps were performed using custom written 
MATLAB R2020a scripts included in NuMorph and are described below. 
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Intensity Adjustments   
Two types of image intensity adjustments were performed on raw images prior to image stitching 
to increase accuracy of subsequent processing. First, uneven illumination along the y dimension 
(perpendicular to the light path) of each 2D image caused by the Gaussian shape of the light sheet was 
corrected using a MATLAB implementation of BaSiC, a tool for retrospective shading correction (139). 
We used 10% of all images, excluding tile positions around the cerebellum, to estimate a flatfield image 
for each channel. Each image was then divided by the flatfield prior to alignment and stitching to correct 
for uneven illumination. Second, differences in intensity distributions between image tile stacks, primarily 
as a result of photobleaching and light attenuation, were measured in the horizontal and vertical 
overlapping regions of adjacent tiles. To ensure bright features were of equal intensity between each 
stack, we measured the relative difference (𝑡 !"#) in the 95th percentile of pixel intensities in 
overlapping regions from 5% of all images. The measured image intensity 𝐼$%!& at tile location (𝑥, 𝑦)was 
then adjusted according to: 
 𝐼 !"#(𝑥, 𝑦) 	= 	 (𝐼$%!&(𝑥, 𝑦) − 𝐷) ∗ 𝑡 !"#(𝑥, 𝑦) + 𝐷 
where 𝐷is the darkfield intensity (set as a constant value based on the 5th percentile of pixel intensities in 
all measured regions). 
 
Image Channel Alignment  
As image channels are acquired one at a time, subtle drift in stage and sample positions during 
imaging may result in spatial misalignment between the reference nuclei channel and the remaining 
immunolabeled markers in a multichannel image. We tested two image registration approaches to ensure 
robust alignment across image channels. The first approach estimates 2D slice translations to align the 
immunolabeled channel images to the nuclear channel image. The axial (z) correspondence between the 
nuclei channel and every other channel within an image stack of an individual tile is first estimated using 
phase correlation at 20 evenly spaced positions within the stack. The correspondence along the axial 
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direction with the highest image similarity (based on intensity correlation) determines the relative tile z 
displacement between channels (up to 50 μm in some cases). xy translations are then determined after 
multimodal image registration for each slice in the tile stack using MATLAB’s Image Processing toolbox. 
Outlier translations, defined as x or y translations greater than 3 scaled median absolute deviations within 
a local 10 image window in the stack, were corrected by linearly interpolating translations for adjacent 
images in the stack. In our data, outlier translations often occur in image slices without any sample 
present where the lack of image contents limits registration accuracy. 
 
While a rigid 2D registration approach is sufficient for channel alignment when samples are 
securely mounted, sporadic movement of some samples during long imaging sessions can result in not 
only shifting translation but also rotational drift. In these cases, performing registration relying solely on 
translation will result in only part of the target image aligning correctly to the nuclei reference at a given z 
position with the remaining misaligned target features appearing in z positions immediately above and/or 
below (Figure 9B). To correct for these displacements, we applied a nonlinear 3D registration approach 
using the Elastix toolbox (104) between channels for each individual tile. Full image stacks were loaded 
and downsampled by a factor of 3 for the x/y dimensions to make the volume roughly isotropic and 
reduce computation time. Intensity histogram matching was then performed and a mask was identified for 
the nuclei reference channel using an intensity threshold that limits sampling positions in the background. 
Next, an initial 3D translational registration is performed on the entire image stack between the reference 
and the remaining channels. The stack is then subdivided into smaller chunks of 300 images and rigid 
registration is performed on each chunk to account for 3D rotation and achieve a more accurate initial 
alignment within local regions of the full stack. Finally, a nonlinear B-spline registration is performed on 
each chunk using an advanced Mattes mutual information metric to account for xy drift along the z axis 
and ensure precise alignment of image features. B-spline transformation grid points were set to be sparser 
along xy compared to z (800x800x8 voxels) as this setting well balances accurate alignment with 
computational cost while also preventing local warping of background intensities.  
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During image processing, the 2D rigid alignment approach was initially used to align each sample. Each 
tile was then visually inspected to ensure accurate alignment of all channels along the stack. For tiles 
where rigid alignment was inaccurate, the non-rigid alignment method was used to correct for 
misalignment. 
 
Iterative Image Stitching  
A custom 2D iterative stitching procedure was used to assemble whole brain images at high 
resolution. First, an optimal pairwise z correspondence along the axial direction was determined for 
adjacent tile stacks by exhaustive image matching for the horizontally and vertically overlapped candidate 
regions. Specifically, a sample of 10 evenly spaced images were taken within a stack and registered to 
every z position within a 20 image window in the adjacent stack using phase correlation. The 
displacement in z with the highest count of peak correlations among the 10 images was presumed to 
represent the best z correspondence. The difference in correlation between the best and the 2nd best z 
displacement was used as a weight for the strength of the correspondence, with a larger difference 
representing a stronger correspondence. This resulted in 4 matrices: pairwise horizontal and vertical z 
displacements and their corresponding weights. To determine the final z displacement for each tile, we 
implemented a minimum spanning tree (140) using displacements and their weights as vertices and edges, 
as previously implemented (141).   
 
An intensity threshold to measure the amount of non-background signal was determined by 
uniformly sampling 5% of all images and calculating the median intensity. The starting point for iterative 
stitching going up/down the stack was selected at a position near the middle of stack with sufficient non-
background signal (set to 1 standard deviation above the darkfield intensity) present in all tiles. 
Translations in xy were calculated using phase correlation and further refined using the Scale Invariant 
Feature Transform (SIFT) algorithm (105). The top left tile was set as the starting point for tile placement 
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for each stitching iteration. This ensures stitched images would not be shifted relative to each other along 
the z axis. Tiles were blended using sigmoidal function to maintain high image contrast in overlapping 
regions. Spurious translations, defined as translations greater than 5 pixels in x or y from the previous 
iteration, in images that lacked image content were replaced by translation results from the previous 
iteration. 
 
Image Registration to ARA Using Point Correspondence 
Volumetric image registration was performed using Elastix to measure the correspondence 
between the stitched TO-PRO-3 channel in the tissue cleared samples and the Nissl-stained Allen 
Reference Atlas (ARA) (108, 142). The atlas and corresponding volume annotations from Common 
Coordinate Framework v3 were downloaded using the Allen Software Development Kit (SDK) 
(https://allensdk.readthedocs.io/) at 10 μm/voxel resolution. In each registration procedure, the ARA was 
downsampled to 25 μm/voxel resolution to perform registration and the resulting transformation 
parameters were rescaled and applied to the  annotation volume at the native 10 μm/voxel resolution.  
 
For registration without point guidance, an affine followed by B-spline transformation sequence 
was applied along 3 resolution levels to each sample using advanced mattes mutual information (MMI) as 
the sole metric to estimate spatial correspondence (as done previously in (62)). This registration 
procedure allowed for direct mapping of ARA annotations to each registered sample and was applied to 
all WT hemispheres in the Top1 study. Adding point guidance to WT samples resulted in similar 
registration accuracy but slightly higher variation in structure volumes between samples (Figure 12).  
 
A modified version of the standard registration procedure without points was also used for 
mapping control and Nf1 cKO hemispheres in the Nf1 study as this knockout model exhibited a lower 
degree of morphological variation compared to the Top1 cKO model. However, to further improve 
registration accuracy, we incorporated additional spectra from tissue autofluorescence that was mapped to 
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the ARA average MRI template, in addition to the TO-PRO-3/Nissl mapping. The downsampled 
autofluorescence channel in each sample was initially pre-aligned to the TO-PRO-3 reference using rigid 
registration and the standard B-spline registration with the ARA Nissl/MRI templates proceeded while 
maximizing the joint mutual information correspondence between the channel pairs. 
 
For points-guided registration in the Top1 cKO model, we first manually placed 200 landmarks 
within both the ARA and our to-be-registered nuclei reference image, using the BigWarp plugin in Fiji 
(143). The majority of points were located within or around the cortex, as this was our region of interest 
and contained the largest deformations in the Top1 cKO samples (Figure 13). The same set of reference 
point coordinates in the ARA were selected for each sample and used as input points in Elastix for affine 
and B-spline registration along 3 resolution levels. Estimates of spatial correspondence for points-guided 
registration was driven by a hybrid metric based on (1) minimizing the point distances between two 
images and (2) maximizing the voxel-wise image similarity between two images which is measured by 
mattes mutual information (MMI). For affine registration, voxel-wise similarity (based on MMI) was 
ignored and only points distance was used to estimate global translation, rotation, and scaling 
transformations. For B-spline registration, we gradually increased the influence of voxel-wise  similarity 
in the hybrid metric during the registration sequence from coarse to fine resolution (1:0.2, 1:0.4, 1:0.6; 
MMI:Point Distance weight). The inverse of the final transformation parameters was then calculated 
using a displacement magnitude penalty cost function (144) and applied to the Allen Mouse Brain 
Common Coordinate Framework v3 annotation volume to assign anatomical labels for each voxel in the 
native sample space. While a more direct approach would be to register the ARA to the sample, we found 
that registering the sample to the ARA and calculating the inverse achieved slightly higher accuracy in 
Top1 cKO brains (data not shown).  
 
To evaluate registration accuracy, 3D masks of the entire isocortex were manually labeled for 
each sample in Imaris (Bitplane) using the 3 acquired channels as markers to delineate cortex boundaries. 
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Some cortical subplate structures, such as the claustrum, were included in the final mask as these were 
difficult to distinguish from the isocortex. The DICE similarity score was then calculated between each 
mask and all cortical structures in the registered annotation volume (Figure 3B) as a metric of registration 
accuracy. 
 
Cortical Volume, Surface Area, and Thickness Measurements 
Quantitative measurements for the volume, surface area, and thickness of the isocortex and 43 
cortical areas defined in (89) or a lower level set of 17 cortical areas (ARA structure depth=6) were 
calculated based on registered annotation volumes. The voxel sums (at 10 um3/voxel) represent the total 
volume of each structure. To calculate volumetric displacement for each sample relative to the Allen 
atlas, the spatial Jacobian was measured for each set of transformation parameters, which ranges from -1 
to 1, and represents voxel-wise local compression or expansion. Surface area for the isocortex was 
calculated based on MATLAB’s implementation of Crofton’s formula (145). The fraction of layer 1 
boundary voxels over all boundary voxels was used to determine the area of only the outer cortical 
surface. This measurement was then further partitioned by the number of layer 1 boundary voxels for 
each individual structure. To calculate thickness, the center of mass for layer 1 and layer 6b were first 
calculated for each structure. Thickness was then measured based on the euclidean distance between 2 
points within layer 1 and layer 6b that were nearest to the centers of mass. Average thickness of the full 
isocortex was weighted by the volume contribution of each structure.  
 
Nuclei Detection 
Imaging data for training the 3D-Unet model was acquired from 3 separate imaging experiments 
of TO-PRO-3 labeled nuclei across 5 different regions from the cortex of 2 WT brains. Images were 
captured at 0.75x0.75x2.5 μm/voxel for training a high resolution model or 1.21x1.21x4 μm/voxel for 
training a low resolution model. A binary approximation of the nucleus volume was initially pre-traced 
using the cell detection component of the CUBIC-informatics pipeline (69). Specifically, the thresholded 
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Hessian determinant after Difference-of-Gassian filtering was used to create an initial 3D mask of all 
nuclei in the image. Full images were then divided into patches of 224x224x64 voxels and preprocessed 
using min/max normalization. The corresponding 3D mask for each nucleus was reduced to its 2D 
component at the middle z position. Each patch was then manually inspected and corrected for 
segmentation error or incorrect shapes using BrainSuite v17a (146) by 1 rater (OK) to reduce person-to-
person variability. The corrected 2D nuclei masks were then eroded by removing 40% of the outer edge 
pixels. Each patch was then subdivided into 4 smaller patches of 112x112x32 voxels, with 1 out of the 4 
patches being withheld for the validation set. The full dataset (training + validation) contained 16 patches 
at 224x224x64 voxels for both the high (14,554 nuclei) and low resolution (53,993 nuclei) models. Nuclei 
at the edge of an image stack were also included in the training. Manually labeled data are available at 
https://braini.renci.org/ using the Download Image service. 
 
A modified 3D-Unet architecture (106, 107) was used to identify the positions of cell nuclei in 
whole cortex images. We built upon and modified a previous Keras implementation of 3D-Unet for 
volumetric segmentation in MRI (https://github.com/ellisdg/3DUnetCNN) to detect binary masks of cell 
nuclei positions. As originally described (107), the 3D-Unet architecture contains a series of context 
modules during the contracting path that encodes abstract representations of the input image, followed by 
a series of localization modules on the upscaling path to localize the features of interest (Figure 13A). We 
similarly used a model with 5 context modules, residual weights, and deep supervision in the localization 
modules. The network was trained using 32 base filters on image patches of size 112x112x32 voxels with 
a batch size of 2. Training presumed over ~300 epochs using an Adam optimizer with a dropout rate of 
0.4 and an initial learning rate 0.002 that was reduced by a factor of 2 for every 10 epochs without the 
loss improving. Additional image augmentations were implemented during the training to make the 
model more generalizable. These include random image permutations, image blurring and sharpening, the 
addition of random noise, and intensity variations along x,y,z dimensions in the image patch. Random 
scaling was removed as we found that this decreased model performance.  
 60 
Nuclei detection accuracy was evaluated using an independent set of 5 images patches of TO-
PRO-3- labeled nuclei where the full 3D volume of each nucleus was fully manually drawn with a unique 
index at 0.75x0.75x2.5 μm/voxel resolution (~3,500 nuclei total). Each patch was sampled from a unique 
region within 1 WT cortex. Evaluation patches were initially delineated by 4 raters and further refined by 
1 rater to reduce between-rater variability. We compared our 3D-Unet detection method with those used 
in 2 previously published pipelines for tissue cleared image analysis: ClearMap and CUBIC-informatics 
(62, 69). For ClearMap, we used voxel size and intensity thresholds after watersheding, as described in 
the published implementation. Parameters for cell size and intensity were scaled accordingly to achieve 
the most accurate average cell counting results possible for all the patches tested. Similarly, intensity 
normalization and Difference-of-Gaussian scaling parameters used in CUBIC-informatics were adjusted 
according to image resolution. Filtering by intensity and structureness was also performed as described in 
the previous work (69) . 
 
In our evaluation of nuclei detection, precision is the proportion of nuclei correctly predicted out 
of all nuclei predictions in an image patch. Precision is therefore calculated by counting the number of 
cells with multiple predicted centroids in 1 manually labeled nucleus volume as well as false positives 
cells called in the image background divided by the total number of nuclei detected and subtracting this 
number from 1. Recall is the proportion of all nuclei instances that were predicted. Recall was therefore 
calculated by counting the number of manually labeled cell volumes that lacked any predicted cell 
centroids divided by the total number of cells. The majority of false negative cases were due to touching 
nuclei. Nuclei whose centroid were within 3 voxels of the image border were excluded from the 
evaluation.  
 
Whole brain TO-PRO-3 images were divided into chunks of 112x112x32 voxels to be fed into 
the trained 3D-Unet model for prediction of cell centroids. An overlap of 16x16x8 voxels was used 
between adjacent chunks to minimize errors from nuclei at chunk edges. Centroid positions falling in a 
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region less than half the overlap range (i.e. <8 pixels from xy border or <4 pixels from z border) were 
assumed to be counted in the adjacent overlapping chunk and were removed. Additionally, a nearest 
neighbor search using kd-trees (147) was performed to remove duplicate centroids within 1.5 voxels of 
each other, ensuring centroids in overlapping regions were not counted multiple times. Increasing overlap 
did not significantly affect the final cell counting results (data not shown). Total computation time for 
detecting all cortical nuclei in 1 WT brain hemisphere was ~2.5 hours using a single GPU. 
 
Cell-type Classification  
To classify cell-types, we took a supervised approach by training a linear Support Vector 
Machine (SVM) classifier using MATLAB’s Statistics and Machine Learning Toolbox on a set of 
intensity, shape, and annotation features within a 2D patch surrounding each centroid. First, channel 
intensities were measured at centroid positions for each channel. Cells with intensities below the median 
for both Ctip2 and Cux1 were presumed negative for both markers and removed from model training and 
classification (~25% of cells). In the remaining cells, we took a uniform, random sample of 1,000 cells 
from each brain image dataset and retained 2D patches (13x13 pixels) around centroid positions. Manual 
classification required >1 hour per dataset using a custom NuMorph function that allows fast navigation 
between cell patches. For each patch, we recorded several intensity measurements (max, mean, standard 
deviation, middle pixel, middle pixel/edge pixel) and applied Otsu thresholding to capture shape 
measurements (total filled area, inner filled area) in each channel. These were also combined with 
categorical annotations for cortical layer (L1, L23, L4, L5, L6a, L6b) and cortical area (Prefrontal, 
Lateral, Somatomotor, Visual, Medial, Auditory; defined in (89). Cells were then manually classified into 
4 classes: (1) Ctip2-/Cux1-, (2) Ctip2+/Cux1-, (3) Ctip2-/Cux1+, (4) Outlier. The outlier class was 
annotated according to 4 additional subdivisions due to differences in intensity features: (1) 
Ctip2+/Cux1+, (2) Pial surface cell, (3) TO-PRO-3-/Ctip2-/Cux1- (4) Striatal cell (only present in Top1 
cKO from residual registration error near white matter boundary). The SVM model was then trained using 
all intensity, shape, and annotation features. Model accuracy was evaluated using 5-fold cross-validation 
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and applied to the remaining cells for classification. Due to differences in labeling intensity between 
samples, we trained a new model for each sample instead of aggregating annotation data. 
 
We compared supervised cell classification with an unsupervised approach based on modeling 
fluorescence intensities at centroids positions as Gaussian mixtures (GM) for Ctip2 and Cux1. After Z 
normalization, high intensity cells (Z > 5 and Z < -5) winsorized and outliers expressing both markers 
near the sample edge were removed. GM model fitting was then performed separately on normalized 
Ctip2 and Cux1 intensities using 2 or 3 components (whichever had higher accuracy by visual inspection) 
for 20 replicates using parameters initialized by k-means++ (148).  Due to spatial variation in gene 
expression, we stratified GM model fitting to 6 general areas defined in (89) according to each cell’s 
structural annotation to further improve accuracy. We then calculated posterior probabilities of each cell 
being positive for either marker. Cells with a posterior probability greater than 0.5 of not being 
background were classified as positive. As the vast majority of neurons do not co-express Ctip2 and Cux1 
(149), we filtered Ctip2+/Cux1+ cells according to their layer annotation. Cells in L1-L4 with P(Cux1) > 
P(Ctip2) were classified as Cux1+ and cells in L5-L6b with P(Ctip2) > P(Cux1) were classified as 
Ctip2+. The remaining Ctip2+/Cux1+ cells were classified as outliers. 
 
Quantification, Statistical Analysis, and Visualization 
Final cell-type counts were summed for each annotation in the cortex according to its structure 
tree hierarchy. In our analysis, we chose to compare either 43 cortical areas defined in (89) or a lower 
level grouping of 17 regions based on the ARA structure hierarchy. Statistics, including mean counts, 
standard deviation, fold change, raw p values, and false discovery rate (FDR) adjusted p values 
(Benjamini-Hochberg; FDR < 0.05), were calculated in MATLAB and exported for plotting using custom 
R scripts and customized slice visualization. Structure volumes were also used to calculate cell density 
statistics. Unless stated otherwise, descriptive statistics in the main text and error bars in figure plots 
represent mean ± standard deviation. 
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2D slice visualizations were created using a custom MATLAB program based on the 
allenAtlasBrowser in the SHARP-Track tool (150). Structure annotations were downsampled along the 
anterior-posterior axis to reduce memory overhead for smoother performance and colored by volume, cell 
count, or cell density statistics. Additional visualizations for point clouds, surface volumes, and flattened 
isocortex plots were created using custom MATLAB scripts and are available in the NuMorph package. 
Additional animations were generated in Imaris (Bitplane) after importing cell centroid position as 
“spots” objects. 
 
Spatial Gene Expression Correlation 
Fold change in cell counts between WT and Top1 cKO were correlated with spatial gene 
expression based on in situ hybridization measurements from the Allen Mouse Brain Atlas (108). 
Expression grid data from sagittal and coronal sections were downloaded using the Allen SDK. 
Expression energy for each gene was first Z-scored across all brain structures and cortical regions were 
retained for analysis. Duplicate sections for the same gene were combined by taking the mean Z score for 
each structure across sections. We filtered out any gene that did not have expression data in all cortical 
structures and removed genes with Z scores less than 1 in all structures as these represent genes with 
consistently low cortical expression or with low congruence between duplicate sections. For the 
remaining genes, we applied a robust sigmoidal transformation as described in (151) to account for the 
presence of outliers in ISH expression data. As certain cortical regions also have greater cell density and 
therefore greater total ISH energy, we conducted an additional Z score normalization across cortical 
regions to have the same average total gene expression. 
 
To reduce known false positive associations from gene-gene coexpression (109), we ran 
comparisons to ensemble-based random null models generated using the Gene Category Enrichment 
Analysis toolbox (https://github.com/benfulcher/GeneCategoryEnrichmentAnalysis). Null distributions 
were generated for GO categories containing between 10 and 200 genes by 10,000 random samples to 
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create a Gaussian distribution estimate of each GO null distribution. In total, we used null models for 
4,186 GO categories based on expression of 10,945 genes across 38 cortical structures. Correlations 
between spatial gene expression and relative cell count differences were tested and corrected for multiple-
hypothesis testing using a false discovery rate of 0.05. Additional annotations for gene length 
comparisons were downloaded from Ensembl (152). The Spearman correlation between each gene’s 
expression and cell count or density differences across cortical regions was measured and binned by gene 
length based on the longest isoform for each gene. The mean and standard deviation of all correlation 
coefficients in each bin (<100kb or >100kb) was used to compare correlation coefficients between bins 
(Welch’s t-test). A list of differentially expressed genes in Top1 cKO cortex as measured by scRNA-seq 
was acquired from (44) for additional comparisons. 
 
Brain Section Preparation and Immunofluorescence Staining 
For histological studies, mice were anesthetized and perfused transcardially with 4% 
paraformaldehyde (PFA) /1XPBS. Brains were dissected and postfixed in 4% PFA for 16 hours. Brains 
were embedded in 4% low-melting point agarose/1XPBS and sectioned using Leica VT1200 vibratome.  
Sections were stored in 1XPBS at 4°C. 
 
For immunohistology studies, sections were rinsed in PBS and incubated in blocking solution 
(5% normal serum, 0.3% Triton X-100, 2% DMDO, 0.02% Sodium Azide,1XPBS) at room temperature. 
Primary antibodies were diluted in blocking solution and incubated overnight at room temperature. The 
following antibodies were utilized for immunofluorescence: rabbit anti-Cux1 (Santa Cruz, sc-13024; 
1:500), rat anti-Ctip2 (Abcam, ab18465; 1:1000), rabbit anti-Satb2 (Abcam, ab51502; 1:1000), goat anti-
GFAP (Abcam, ab53554; 1:1000) and rabbit anti-Olig2 (Millipore, AB9610; 1:2000). Brain sections were 
rinsed in 0.1% Triton-X 100/1XPBS (PBS/T) three times and incubated with secondary antibodies in 
blocking solution for 3 hours at room temperature. Secondary antibodies utilized include donkey anti-
rabbit IgG Alexa Fluor 568 (Thermo Fisher, A10042; 1:1000), goat anti-rat IgG Alexa Fluor 488 (Thermo 
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Fisher, A11006; 1:1000) and donkey anti-goat IgG Alexa 488 (Thermo Fisher, A11055; 1:1000). Sections 
were then stained with DAPI (1:1000 in PBS/T) and rinsed with PBS/T three times for 20 minutes each. 
Sections were mounted onto Fisherbrand Superfrost/Plus slides with antifading Polyvinyl alcohol 
mounting medium with DABCO (Sigma-Aldrich, 10981). Images were collected with a Zeiss LSM 780 
laser scanning confocal microscope. 
 
EdU Labeling and Detection 
To permanently label newly generated cortical neurons, pregnant dams at E16.5 were single-
dosed with 5–ethynyl–2′–deoxyuridine (EdU, Cayman Chem) in 1X PBS at 30mg/kg body weight via 
intraperitoneal injection. Pups were perfused at P14 and sectioned as described above. EdU detection was 
conducted upon the completion of immunofluorescence labeling. After washing in PBS for 10 minutes, 
brains sections were incubated with Alexa 647-conjugated Azide (Biotium) at 1.6µM, in solution 
containing 0.1M Tris-HCl (pH 8.8), 0.43 X PBS, 4 mM CuSO4, and 0.1M Ascorbate, for 20 minutes.  
Brains sections were washed with PBS/T three times at 20 minutes each, stained with DAPI and mounted 
for confocal imaging.  
 
Confocal Image Analysis and Quantification 
Confocal images of barrel fields from 2D slices were collected for cortical thickness and cell 
number analysis. Images were acquired from anatomically matched coronal sections along the rostro-
caudal axis. The distribution of cortical upper layer (layer 2-4) marker, Cux1, was utilized to determine 
the boundaries separating layer 1, upper layers and lower layers (layer 5-6). The thickness of an 
individual layer was measured along the middle segment of selected regions of interests (ROIs). For cell 
number assessment, images were processed using ImageJ (https://imagej.net/ImageJ). Briefly, images 
were auto-thresholded at default setting with manual adjustment to eliminate unfocused signals and 
binary images were watershedded. Numbers of Cux1, Ctip2 and Olig2 expressing cells were 
automatically determined using the Analyze Particles function with a cut off size at 17.5µm2. To 
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determine EdU-labeled cortical neurons, EdU and Satb2 co-labeled cells were extracted and cell numbers 
were automatically determined using the Analyze Particles function with a cut off size at 35.0µm2. GFAP 
expressing cells in the cortical plate were counted manually in Photoshop after thresholding using ImageJ. 
Representative images were cropped and adjusted for brightness and contrast in Photoshop for 
presentation. Mice from a minimum of three litters were analyzed for each experiment. 2 to 3 ROIs were 
analyzed and results were averaged from each animal. For all experiments, n represents the number of 
animals. One-way ANOVA analyses with post hoc Tukey's tests were performed in GraphPad Prism 9.  
 
Data and Code Availability 
NuMorph source code is available at https://bitbucket.org/steinlabunc/numorph/. Manually 
labeled annotations for 3D-Unet training and raw light-sheet images are available at 
https://braini.renci.org/ through the “Download Image” service. 
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CHAPTER 3: SEGMENTOR: A TOOL FOR MANUAL REFINEMENT OF 3D MICROSCOPY 
ANNOTATIONS 
3.1 Introduction 
The structure of the brain provides the machinery that enables behavior and cognition. The 
human brain is extremely complex, comprising ~170 billion cells, of which ~86 billion are neurons (153). 
The mouse brain, a common model system used to study brain-behavior relationships, is much smaller yet 
still has ~109 million cells, ~70 million of which are neurons (153). By mapping the location of these 
many brain cells, classifying them into types based on the expression of marker genes, and determining 
how cell type proportions and locations are altered by mutations or environmental factors, we can 
understand how changes in brain structure lead to changes in behavior and/or cognition. 
 
In order to map cell types within intact brains, a number of tissue clearing techniques for making 
the brain transparent were recently introduced (54, 92). Combined with high-speed image acquisition 
through light sheet microscopy, the full 3D extent of adult mouse brain specimens can be imaged at 
micron resolution in a matter of hours (154–157).  
 
Currently, these large-scale microscopy images are often used for qualitative visualization rather 
than quantitative evaluation of brain structure, thus potentially overlooking key spatial information that 
may influence structure-function relationships for behavior and cognition. In order to quantify objects 
within annotated regions of the images, we need to distinguish morphological objects of interest (e.g., 
nuclei) from background (80). Existing programs that perform object segmentation in cleared samples 
from tissue (for example, ClearMap (62), CUBIC (98)) or organoids (158) work well for cases with 
unambiguous morphological characteristics. However, for cases in which morphological objects are 
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densely packed, nuclei segmentation results are less accurate using current computational tools, which 
obfuscates brain structure quantifications and comparisons. Recent deep learning-based nuclear 
segmentation algorithms such as multi-level convolutional neural networks show great promise for more 
accurately identifying each individual nucleus (159–162). When colocalized with immunolabeling, 
nuclear segmentation additionally enables counting individual cell types. Present learning-based methods 
require two sets of manually labeled ‘gold standards’: (1) a large number of training objects to learn the 
morphometrical appearance of nuclei in the context of various backgrounds, and (2) independent 
benchmark datasets for evaluating the accuracy of automated segmentation results.  
 
Gold standard datasets are derived from manual labels by trained and reliable raters. Manual 
labeling is both time-consuming and difficult because of ambiguities in nuclear boundaries and the 
difficulty of labeling 3D structures on a 2D screen. A few tools have been developed for manual labeling 
of objects in 2D (163) and 3D (146, 164–166) images, including labeling in virtual reality environments 
(167). Existing annotation software often implement automatic contour completion using deformable 
model techniques such as active contour (168). This feature is useful when nuclei are spatially separate 
from each other, but is less powerful for annotating densely-packed nuclei, where the boundary between 
multiple nuclei has lower contrast. Additionally, existing tools are not optimized for editing large images 
with high visual complexity where densely packed nuclei within a 3D scene can obscure the region being 
edited, and, at present, do not provide methods for semi-automated correction of common automated 
segmentation errors (e.g., incorrectly merged or split nuclear boundaries) that lower throughput of manual 
refinement.  
 
Here, we present Segmentor, an open-source tool for reliable, efficient, and user-friendly manual 
annotation and refinement of objects (e.g., nuclei) within 3D light sheet microscopy images. This tool 
enables automated pre-segmentation of nuclei, refinement of objects in 2D and 3D, visualization of each 
individual nucleus in a dense field, and semi-automated splitting and merging operations, among many 
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other features. This tool has been used by 10 individuals to achieve reliable segmentation and labeling of 
thousands of nuclei. We show that editing simultaneously in both 2D and 3D significantly decreases 
labeling time, without impacting accuracy. Software releases of this tool and example images are 
available at https://www.nucleininja.org/, and source code and documentation are available at 
https://github.com/RENCI/Segmentor. We expect that increasing the number of manually labeled nuclei 
in 3D microscopy images through this user-efficient tool will help implement fully automated nuclear 
recognition by incorporating deep learning. 
 
3.2 Implementation 
Software 
The Segmentor tool was developed in C++ using open-source cross-platform libraries, including 
VTK (169) and Qt (170). 3D image volumes and segmentation data can be loaded in TIFF, NIfTI, or VTI 
format. In order to increase efficiency, the tool is primarily designed for manually refining existing 
annotations rather than beginning annotations completely anew. The user can load initial segmentation 
data generated by a tool external to Segmentor (e.g., NuMorph (159), CUBIC (98), or ClearMap (62)), or 
generate an initial global intensity threshold-based segmentation (171) from within Segmentor. The 
interface consists of panels with 2D (right panel) and 3D (left panel) views and a region table (Figure 16). 
The 2D view consists of a single slice through the volume, and enables the user to see both the voxel 
intensities, and 2D visualizations of the segmented regions. The 3D view enables the user to see 3D 
surfaces of the segmented regions, and inspect them for non-uniform morphology that is difficult to 
visualize using only the 2D view. The 3D and 2D views are synchronized, such that navigating (i.e., 
rotating, translating, or zooming) in one view also updates the other view. The hybrid 2D/3D 
visualization and editing capabilities are important as each view is useful for different aspects of the 
annotation procedure, e.g., the 2D view is useful for manually selecting voxels based on image intensity, 
whereas the 3D view is useful for identifying incorrectly segmented regions of densely packed nuclei.  
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Visualization features  
The 2D view provides outline and filled representations of the segmented regions, and 
window/level controls for the voxel intensities. The 3D view has controls for smooth shading and surface 
smoothing. The user can also toggle a representation of the current 2D slice plane in the 3D view. Edits 
made in either view are immediately updated in the other view. To reduce visual clutter in the 3D view, 
various modes are available to filter the currently visible regions to: 1) current slice plane, 2) the currently 
selected region and close neighbors, and 3) the currently selected region only.  
 
Editing features 
Various editing features are provided. Most operations can be applied in either the 2D or 3D 
view, although certain features are only applied in the 2D X-Y plane due to the improved resolution in 
that plane for most microscopy volumes. Standard editing features include voxel-level painting and 
erasing of the currently selected region. The user can select a brush radius, applied in the X-Y plane, for 
these edits.  
 
In addition to these standard editing features, more advanced features are also provided. The user 
can apply a constrained region growing or shrinking operation in the X-Y plane by selecting a voxel 
outside (growing) or inside (shrinking) the current region. For region growing, all voxels with an intensity 
equal to or higher than the selected voxel that are reachable from the current region, and no farther than 
the selected voxel, are added to the region. This is similar to a dilation of the current region, but only 
including voxels with intensities greater than or equal to the current region. Region shrinking works 
similarly, but removes voxels with intensities less than or equal to the selected voxel.  
 
Common segmentation problems from automatic methods include divided nuclei, where more 
than one region is present within a single nucleus, and joined regions, where multiple nuclei are 
incorrectly included as the same region. Semi-automated methods are provided for correcting these 
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issues. To fix divided nuclei, the user can select any region to merge with the current region by 
reassigning the voxel labels. Splitting joined regions is more challenging (Figure 17). We employ an 
intensity threshold method: using the 2D and 3D view the user determines how many nuclei are in the 
current region that should be separated. After specifying this number, a fully-automated approach is 
applied. An increasing intensity threshold is repeatedly applied to the voxels in the region. As the 
intensity increases, the region is typically broken up into smaller regions. The threshold resulting in the 
specified number of regions (via connected component analysis) with the largest volume for the smallest 
of the three regions (making the method less sensitive to noise) is used to define seed regions (intensities 
are typically higher toward the center of the nuclei). Each seed region is then successively grown 
similarly to the region growing method described above, by stepping the region growing intensity down 
from the seed region threshold, constraining the growing to a 1-voxel radius at each step, and to the 
original region voxels. After splitting, the user can perform any necessary adjustments using the other 
editing features. 
 
Region table 
To help the user manage the complexity of segmenting many nuclei in a given volume (e.g. ~460 
nuclei are found within an image volume of 152.5 μm x 152.5 μm x 248 μm of the cortex), a region table 
provides information on each segmentation region, including label color, size (in voxels), modified status 
(whether the label has been modified since the last save), and done status (whether the user considers 
segmentation complete for that region). The user can sort by label, size, or status, and select any region to 
zoom in on that region in the 2D and 3D views. The user can mark any region as done to keep track of 
their progress. Such regions will be greyed out in the other views. Modified and done statuses are stored 
in a separate JSON metadata file stored with the segmentation data. 
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Editing features 
All users undergo an initial training period in which they receive the same standardized training 
image containing 39 nuclei. Each user then generates an initial automated segmentation, which s/he 
manually edits. Labeling reliability is then iteratively assessed by comparing segmentations to those of an 
experienced rater (CMM) until a Dice score (172) of ≥ 0.85 is achieved and label counts are within ± 1 
nucleus of the ‘gold standard’ training segmentation (i.e., 39 ± 1 nuclei).  
 
Case study 
To quantify efficiency and accuracy of manual labeling in 2D+3D as compared to 2D alone, two 
raters (CMM, NKP) manually refined a series of four images using either ‘2D only’ or ‘2D+3D’ 
visualizations. Both raters used Segmentor v0.2.11 (Windows version) and achieved reliability on a 
separate standardized image prior to beginning the case study. One rater (NKP) was assigned these 4 
images balanced with respect to the order of ‘2D only’ or ‘2D+3D’,  to minimize ordering bias. This rater 
alternated between ‘2D only’ and ‘2D+3D’ using a toggle-enabled feature in Segmentor’s interface 
designed to hide the 3D visualization. In total, this rater completed 2 manual refinements on each of 4 
images (i.e., labeling the same image twice per visualization modality). The other rater (CMM) edited 
each of the four images in ‘2D+3D’ only for accuracy assessment. Both tracers recorded the time to 
completion using the freely available Clockify application. Manually refined annotations were compared 
between raters for accuracy (Dice score, DSC) and differences in time and accuracy between ‘2D only’ 
and ‘2D+3D’ were evaluated using a paired t-test. 
 
Image acquisition 
Images used as input to Segmentor were acquired from iDISCO+ (62) tissue clearing of P15 
C57Bl/6J mice. Nuclei were labeled with TO-PRO-3 and imaged on a lightsheet microscope 
(Ultramicroscope II from LaVision Biotec) at a final resolution of 0.75 μm x 0.75 μm x 2.50 μm. Blocks 
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from the cortex were used for labeling with Segmentor. Further details about image acquisition can be 
found in (159). 
 
User survey 
Segmentor usability feedback was collected from six participants in a 28-question survey (24 
Likert scale questions on a 7-point scale, in which ‘1’ means ‘not useful’ and ‘7’ means ‘extremely 
useful,’ followed by 4 open-ended questions). QualtricsXM was used to distribute the survey and analyze 
participant results (see Supplementary Information). 
 
3.3 Results 
Ten users have used Segmentor for manual refinement of 3D microscopy volumes. 
Segmentations from one expert user were defined as the gold standard and results from every other user 
were compared to this segmentation via Dice score and nuclei counting to assess reliability. After 5 
iterations, a Dice score of ≥ 0.85 was achieved by each user (average final Dice score=0.876). 
 
To test whether simultaneous visualizations of 2D and 3D segmentations led to increased 
efficiency or accuracy, we designed a case study in which one user labeled nuclei using either the 2D 
view alone or both the 2D and 3D view in 4 images containing on average 39 nuclei. A separate expert 
user annotated the same images with both the 2D and 3D view to serve as gold standard for accuracy 
comparisons. The use of both 2D and 3D led to a 1.8-fold reduction in the amount of time needed for 
segmentation (2D: 554 +/- 15 min; 2D+3D: 304 +/- 21 min; p=0.00027; Figure 18). Using both the 2D 
and 3D view, manual annotation of the full 3D extent of a nucleus takes approximately 8 minutes. 
However, we found that use of both 2D and 3D views was not associated with differences in annotation 
accuracy relative to the gold standard rater (mean Dice score for 2D: 0.82 +/- 0.024; mean Dice score for 
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2D+3D: 0.81 +/- 0.023; p=0.86; Figure 18). These findings indicate that combined use of the 2D and 3D 
views increase speed for manual refinements without sacrificing accuracy in segmentation.  
 
The user survey corroborated with case study results, as 2D and 3D views were both found to be 
useful. Questions focused on the usefulness of editing segmentations in 2D and 3D received respective 
means of 6.33 (Q1) and 6.83 (Q2) on a 7-point Likert scale, and questions focused on the usefulness of 
2D and 3D visualizations received respective means of 5.5 (Q3) and 7.0 (Q4). The region splitting feature 
was also confirmed to be useful, with a mean of 6.67 (Q6), and questions addressing features related to 
the region table had an overall mean of 6.63 (Q11-14). Visualizing non-axis-aligned slices in the 2D view 
supports synchronization of the 2D and 3D views, but scores on the utility of this feature varied, with a 
mean value of 3.33 and a standard deviation of 2.43 (Q10), perhaps due to artifacts caused by voxel 
anisotropy. Future work will explore more flexible coupling of the 2D and 3D views to more effectively 
utilize the strengths of each view.   
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Figure 16. Demonstration of Segmentor software for nuclear refinement.  
(a) Raw microscopy volumes of the brain are loaded into the software.  
(b) Segmentor provides an initial segmentation of nuclei within the image (alternatively, pre-
segmentations from other programs can be loaded).  
(c) The segmented images are manually refined within Segmentor using (1) the 3D visualization of 
segmented nuclei and (2) the 2D slices. (3) The region table enables the user to track progress during 
segmentation.  
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(d) Finally, the manually refined image that can be used as gold standard input to deep learning programs 
is shown (grey regions indicate those the user has marked as completed). Image made in part using 
BioRender.  
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Figure 17. Examples of automated nuclear splitting within Segmentor.  
(a) An incorrectly joined region is shown (top), which after visual inspection is determined to represent 
two nuclei. After the user specifies that there are two nuclei in the joined region, the automated splitting 
function result is shown (bottom).  
(b) Similar to (a), but three nuclei are incorrectly joined (top) and the automated result is shown (bottom).  
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Figure 18. Case study to determine accuracy and efficiency of manual refinement when visualizing 
2D and 3D nuclei.  
(a) Dice score measuring accuracy relative to an expert rater for either the labels only from the 2D 
segmentations or from 2D + 3D segmentations.  
(b) Time comparison between 2D vs 2D+3D.   
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3.4 Discussion 
A user-friendly tool for manual delineation of nuclei in 3D image volumes will greatly accelerate 
training of automated recognition algorithms necessary to quantify nuclei in tissue cleared images of the 
brain. Here, we present Segmentor as a tool to make manual 3D segmentations easier and more efficient. 
Segmentor has been tested and iteratively updated based on the feedback of 10 users. Segmentor provides 
new features that allow the user to parse relevant information and navigate in dense images, automatically 
split or merge nuclei, keep track of progress during segmentation, and efficiently use both 2D and 3D 
visual information. While we have demonstrated use-cases for nuclear segmentation, Segmentor also can 
be used to annotate any other features found in 3D microscopy images.  
 
Here, we focus on identifying the borders of the 3D extent of the nucleus rather than using a 
marker to label one voxel within the nucleus. Though counting applications only require one voxel (or 
crosshair) within a nucleus to be labeled, labeling the boundaries of nuclei enables measurements of 
nuclear shape, facilitates more accurate colocalizations with markers across channels, and allows for 
evaluation of precision and recall by determining whether an automated segmentation lies within the 
boundaries of the manually defined nucleus. We also believe that the added information of the nuclear 
boundaries will provide more useful heuristics to deep learning approaches about contextual features that 
distinguish the nucleus from background and possibly other (touching) nuclei (161). 
 
How many manually annotated nuclei are sufficient for training a successful image segmentation 
tool using deep learning methods? In recent work (161), 80,692 manually labeled nuclei (from 1,102 
images) were used to train a highly accurate 2D segmentation method (173). Learning 3D nuclei 
segmentation is more challenging than its 2D counterpart, so it is necessary to develop more complex 
neural networks (with more parameters), which require larger numbers of training samples for fine tuning 
the network parameters. Each 3D nucleus is composed of ~5 slices of 2D segmentations at the image 
resolution used here. Thus, our goal is to acquire ~20,000 high-quality manual 3D nuclei annotations 
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using our Segmentor software (comprising ~100,000 2D masks), which will be used to train, validate, and 
test our neural network in a 10-fold cross validation manner. 
 
We show a case study that visualization in both 2D and 3D views increases efficiency without 
impacting accuracy, while significantly reducing tracing time. Because a large number of training 
samples are needed to train a deep learning-based segmentation model, suggested improvement of manual 
labeling efficiency will greatly contribute to the performance of automated segmentation software. 
Finally, the current approach involves the segmentation of a full 3D image containing 40-400 cells, which 
still can take 5 to 50 hours of manual effort per user. We expect that as automated pre-segmentations are 
improved through additional manual training, time for manual refinement will decrease because less 
manual refinements will be required. Additionally, we expect that by chunking these segmentation tasks 
into smaller units of single cells or clumps of cells, more users can participate in segmentation 
simultaneously with less overall time commitment. This would allow annotations at a massive scale, 
through a larger scale citizen science approach.  
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CHAPTER 4: GENETIC REGULATION OF FOXO3 EXPRESSION INFLUENCES HUMAN 
NEUROGENESIS AND IS ASSOCIATED WITH CORTICAL SURFACE AREA AND 
INTELLIGENECE 
4.1 Introduction 
Human intelligence is a complex behavioral trait that is associated with important life outcomes 
and well being  (174). Recent genome-wide association studies (GWAS) have uncovered hundreds of loci 
influencing human intelligence that are associated with genes expressed in the brain (9, 175). These genes 
were implicated in specific brain-related processes such as nervous system development and synaptic 
structure. Additionally, cognitive ability has also shown high genetic and phenotypic correlation with 
brain structure differences (176). Analysis of causal association using GWAS summary statistics have 
suggested a directional effect of brain volume on intelligence (177, 178). The cerebral cortex makes up a 
large portion of total brain volume and a recent genome-wide analysis of cortical structure also identified 
significant positive genetic influence of cortical surface area (SA) on intelligence (4). While brain 
structure and cognitive function appear highly intertwined, we know little of the molecular underpinnings 
that drive variation in brain structure and how these may impact cognitive ability. 
 
One locus that is associated with both brain volume and global cortical surface area co-localizes 
within the intronic region of the gene FOXO3. Strikingly, this locus was identified as highly significant in 
the largest current GWAS of human intelligence (p-value=7.94x10-22) (9). Functional variants have been 
identified within this region (179, 180) but their impact on FOXO3 expression in brain cell-types have not 
been tested. FOXO3 has been previously shown to regulate the self renewal and homeostasis of adult 
neural stem cells (181, 182). Specifically, downregulation of FOXO3 expression was found to increase 
adult neurogenesis in the subventricular zone of the adult mouse hippocampus (182). As a major 
component of PI3K-Akt pathway, FOXO3 is also a known regulator of cell proliferation (183, 184) and is 
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highly responsive to environmental stimuli such as oxidative stress (185) and IGF1 signalling (186). In 
the fetal brain, specific deletion of FOXO3 within apical neural progenitor cells of the embryonic cortex 
resulted in increased brain size in the adult mouse (181). However, it is unclear how FOXO3 regulation of 
neural stem cell processes during embryonic and/or postnatal development would lead to changes in brain 
morphology.  
 
Cortical structure is shaped by the proliferation and differentiation of neural progenitor cells 
during the period of neurogenesis of fetal brain development. In particular, symmetric divisions of apical 
radial glia  lead to the formation of additional cortical units, thereby driving expansion of the cortex. As 
FOXO3 is expressed throughout the cortex of the developing brain (187), we hypothesized that FOXO3 
may be acting through this cell-type to elicit changes in brain structure. Using primary human neural 
progenitor cells (phNPCs) as a model system, here we deconstruct the cellular and molecular mechanisms 
by which genetic variation at the FOXO3 locus can lead to increased neurogenesis in the developing 
brain. Our results suggest a potential biological basis by which genetic variation in the prenatal brain 
leads to an increase in brain size and a greater capacity for cognitive ability in adulthood.  
   
4.2 Results 
The T-allele of the SNP rs2802292 within the FOXO3 locus reduces enhancer activity and is 
associated with increased cortical SA and intelligence 
To identify functional genomic regions that may be impacted by variants in the FOXO3 locus, we 
analyzed chromatin accessibility data from both bulk fetal cortex and cell-type specific cell cultures (188, 
189). As open chromatin peaks have been found to overlap with enhancer regions (188), functional 
variants are more often located near or within these regions. Within the FOXO3 locus, we located 2 
putative regulatory elements (RE1, RE2) that may affect neural progenitor cell function, marked by open 
chromatin peaks specifically within these cells or in the fetal germinal zone where neural progenitor cells 
are located (Figure 19A). Within or near these peaks, we identified several single nucleotide 
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polymorphisms (SNPs) that are associated with cortical surface area and intelligence (Figure 19B). 
Additionally, RE1 colocalizes with a VISTA enhancer (190), providing additional evidence that this 
region is functional.  
 
Next we looked to identify functional SNPs within the FOXO3 locus by performing statistical 
fine-mapping analysis of intelligence and cortical SA summary statistics using the eCAVIAR framework. 
As the genomic associations patterns were highly similar between intelligence and SA, eCAVIAR 
analysis did not distinguish an individual SNP with high probability of being causal. However, we were 
able to prioritize several SNPs that had higher posterior probabilities than the other variants in the locus 
(Figure 19C). To identify allelic effects on enhancer activity experimentally, we tested 600bp DNA 
elements containing major and minor alleles for 5 candidate SNPs (rs2802288, rs2802290, rs2802292, 
rs2802295, rs2764261) for luciferase reporter expression in phNPCs. For SNPs falling close enough to 
RE1 and RE2, we also cloned the full element that spanned either regulatory element and the SNP-
containing 600bp fragment. From the 7 total pairwise combinations that were tested, only one was shown 
to have allelic effects, rs2802292, which falls near RE1. Interestingly, alleles within the 600bp element 
had no effect on reporter activity for rs2802292 and only when RE1 was present did allelic differences 
begin to appear (Figure 19D). This implies that variation in rs2802292 can modulate the function of this 
particular regulatory element. These results were also previously replicated in 293 cells where the G allele 
of rs2802292 was associated with higher reporter activity (180), as seen here in human neural progenitor 
cells, the cell type of interest. rs2802292 was also identified as an eQTL for FOXO3 in the adult 
prefrontal cortex with the G allele decreasing FOXO3 expression (p-value=7.0828e-05, derived from 
PsychENCODE data) (191). As the G allele of rs2802292 is associated with decreased SA and 
intelligence, this suggests that increased activity of this regulatory element and upregulation of FOXO3  
can lead to decreased SA and intelligence. 
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CRISPRi targeting of regulatory elements in the FOXO3 locus decreases FOXO3 expression and 
leads to increased neurogenesis 
To experimentally validate the functional effects of RE1 and RE2 on FOXO3 gene expression, 
we repressed the activity of these regions using CRISPR interference (CRISPRi) (192) within phNPCs. 
Using a combination of gRNAs targeting RE1 and RE2, we found that inhibition of these elements by 
dCas9-KRAB showed marginal but significant decrease in FOXO3 expression (Figure 20). We note that 
these experiments were performed across multiple unique phNPC donor lines indicating that this effect 
can be measured independent of genetic background. This suggests that RE1 and RE2 are important for 
regulating FOXO3 expression within neural progenitor cells of the fetal cortex. 
 
As FOXO3 is a known regulator of cell proliferation, we then tested whether changes in FOXO3 
gene expression, through modulation of RE1 and RE2 activity, would impact phNPC proliferation. We 
again used CRISPRi to downregulate the activity of these elements and performed immunolabeling 
followed by high content imaging to detect changes in the number of proliferating phNPCs. Our results 
show that repressing RE1, but not RE2, increases phNPC proliferation as determined by KI67 labeling, a 
marker for proliferation (Figure 21A). Next we tested whether this increase in phNPC proliferation would 
lead to enhanced neurogenesis. We differentiated phNPC cultures from 6 unique donors for 10 days after 
CRISPRi targeting and again found significant increase in the number of Sox2+ progenitors (Figure 21B) 
for RE1 as well as Tuj1+ neurons (Figure 21C). For RE2, we saw a slight increase in the number of these 
cell-types but only for some donors and not at the same level as RE1. Overall, these results show that 
inhibiting the activity of regulatory elements in the FOXO3 locus can enhance neural progenitor 
proliferation, which can lead to significant increases in the number of neurons that are generated during 
cortical development.  
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Mendelian randomization analysis identifies causal effects of cortical surface area on higher 
intelligence 
Previous studies have explored the causal relationship between brain size and intelligence where 
a bidirectional association between these phenotypes was noted (178). To further test the causal links 
between intelligence and cortical structure, we performed Mendelian Randomization (MR) analysis of 
cortical SA and intelligence using GWAS summary statistics. Here we also observed bidirectional effects 
between cortical SA and intelligence (Figure 22A). However, the association whereby cortical SA 
mediates changes in intelligence had a much stronger correlation and the FOXO3 locus was one of the 
strongest independent variables driving this association. Based on our experimental results validating the 
effects of FOXO3 on neural progenitor development, we can now formulate a potential pathway at 
multiple levels of biology that links genetic regulation of FOXO3 to differences in neurogenesis, cortical 
SA, and intelligence (Figure 22B). However we note that this mechanism does not eliminate the 
possibility of other pleiotropic factors that could impact cognitive ability, which may also act through 
genetic variation in this region during development and throughout life.  
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Figure 19. The T-allele of rs2802292 is Associated with Increased Cortical Surface Area and 
Reduces Enhancer Activity in Neural Progenitor Cells 
A. Co-localization of the FOXO3 locus with regulatory elements present in neurodevelopmental tissues 
and cell-types. (GZ: germinal zone) 
B. Zoomed-in versions of the regions highlighted in (A) showing GWAS SNPs near or within regions of 
accessible chromatin. 
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C. Fine-mapping results of the FOXO3 locus showing prioritized, putatively causal SNPs. 
D. Allelic differences in enhancer activity for rs2802292 as measured by luciferase reporter assay in 
neural progenitor cells. (n=6 unique NPC donors). 
 
 
 
 
 
 
 
Figure 20. CRISPRi of Targeting of Intronic FOXO3 Elements Decreases FOXO3 Expression 
Relative FOXO3 expression upon lentiviral transduction with dCas9-KRAB targeted to FOXO3 
regulatory elements as measured by qPCR. (**p<0.01, *p<0.05, 2 sample t-test with Holm post-hoc 
correction, n=6 unique donors, mean ± standard error).  
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Figure 21. CRISPRi of Targeting of Intronic FOXO3 Elements Increases phNPCs Proliferation and 
Neurogenesis. 
A. Proportion of phNPCs immunolabeled for proliferation marker Ki67 after CRISPRi targeting of 
FOXO3 regulatory elements as determined by high content imaging analysis. (*p<0.05, 2 sample t-test 
with Holm post-hoc correction, n=6 unique donors, mean ± standard error). 
B-C. Total cell numbers of 10 day differentiated phNPC cultures immunolabeled for progenitor marker 
SOX2 (B) and neuron marker Tuj1 (C) after CRISPRi targeting. (**p<0.01, *p<0.05, 2 sample t-test with 
Holm post-hoc correction, n=6 unique donors, mean ± standard error). 
D. Representative images of immunolabeled phNPCs for Control and RE1 targteting gRNAs. 
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Figure 22. Causal Influences of Cortical Surface Area on Human Intelligence. 
A. Mendelian randomization test for the effect of cortical surface area on intelligence. bzx and bzy indicate 
SNP GWAS effect sizes for their respective traits.  
B. A potential biological mechanism for altering human intelligence by genetic variation in the FOXO3  
locus.  
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4.3 Discussion 
Human brain structure is often associated with our cognitive ability (23, 193) but the underlying 
mechanisms are not fully understood. Here we show how genetic variation near FOXO3 can alter 
neurogenesis in the fetal brain, which can potentially lead to structural changes in the adult cortex and 
differences in intelligence. Gene set analyses have previously implicated neurodevelopment processes 
such as neurogenesis as being highly influential in shaping cognitive ability (9). Our results indicate 
FOXO3 expression regulates the proliferation of neural progenitor cells, thereby identifying a key cell-
type involved in this pathway. FOXO3 has also been associated with adult neurogenesis (182), indicating 
this gene may influence cognition in the adult brain as well (194). However, it is unknown the extent to 
which adult neurogenesis can shape gross brain structure traits such as brain volume or cortical SA. 
Molecular influences in fetal neural progenitors have been shown to be highly influential in determining 
brain morphology (4) and may better explain the high genetic correlation between intelligence and 
cortical SA at the FOXO3 locus.  
 
While modulating RE2 was shown to influence FOXO3 expression, this perturbation did not 
result in significant changes in neurogenesis. Strong overall effects were not detected for either element 
and a larger sample size may have improved the power to detect significant differences. However, the 
topologically assciated domain spanning the FOXO3 locus has also been shown to readily interact with 
nearby genes under environmental stimulation  (195).  These interactions may also potentially impact 
neural progenitor cell fate. Specifically, the gene SESN1 is known to be involved in mTOR signaling 
(196), an important signaling pathway that influences brain development (197, 198). Studies in a cancer 
model have shown that downregulation of both FOXO3 and SESN1 simultaneously can increase tumor 
proliferation to a greater extent than targeting either gene individually (199). Future experiments are 
therefore needed to test whether regulatory elements in the FOXO3 locus may be interacting with other 
genes in the chromatin domain to influence the cellular processes involved in fetal brain development.  
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In addition to intelligence, variation in the FOXO3 locus has been associated with differences in 
human longevity (179, 200, 201) and FOXO3 expression has been associated with age-related phenotypes 
in multiple tissues (184). However, compared to intelligence, the implicated directionality is reversed as 
increased FOXO3 transcription is associated with longer lifespans. Within the aging brain, FOXO3 may 
have a neuroprotective effect and upregulation of FOXO3 was shown to reduce axonal degeneration in a 
mouse model (202). Another study found that changes in FOXO3 expression, by activation or repression, 
induced apoptosis of dopaminergic neurons (203). Therefore the same genetic mechanisms preserving 
neuronal homeostasis later in life may also regulate brain growth during development in a cell-type 
specific manner. Additional studies are needed to disambiguate the molecular interactions across tissue 
types at converging genomic locations associated with multiple complex traits.  
 
4.4 Methods 
Cell culture of primary human neural progenitor cells (phNPCs) 
phNPCs were cultured using the same methods as previously described (86, 188, 189). Multiple, 
unique phNPC donor lines were used for experimentation.  
 
Statistical fine-mapping of causal SNPs 
We performed fine-mapping of the FOXO3 locus using eCAVIAR (204) based on Z scores from 
IQ and SA summary statistics and LD correlation matrices from European ancestry (205). To reduce 
computational time, we used a 200kb region around the lead SNP from the SA association (rs2802295) 
that included all statistically significant SNPs from either dataset. Parameter ρ was set 0.95 and a 
probabilistic model was calculated based on a maximum of 4 causal SNPs.    
 
Mendelian randomization 
Mendelian randomization was performed using the Generalized Summary-data-based Mendelian 
Randomization (GSMR) computational method (206). Summary-level data from SA and IQ associations 
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and LD correlation matrices from European ancestry (205) were used to test for bidirectional causation by 
switching the roles of exposure and outcome between SA and IQ. HEIDI outlier detection was used to 
filter pleiotropic effects using a P value threshold of 0.01. A genome-wide significance threshold of 5x10-
8 with an LD threshold of 0.1 was used to select independent lead SNPs that were implemented as 
instrumental variables.  
 
Luciferase assay 
600 bp DNA elements containing major and minor alleles at five target SNPs (rs2802288, 
rs2802290, rs2802292, rs2802295, rs2764261) were synthesized and cloned into the pGL4.23 vector 
(Promega) containing a minimal promoter and luc2 luciferase reporter using the KpnI and BglII restriction 
sites. Two additional elements spanning the full lengths RE1 and RE2 while containing alleles for 
rs2802292 in RE1 and rs2764261 in RE2 were also synthesized and cloned. A total of 14 unique plasmids 
were generated, midi-prepped, and sequence verified using Sanger sequencing. 
 
phNPCs were plated in 96-well plates at 30,000 cells per well. The next day, cells were 
transfected with 120 ng of a luc2 luciferase reporter plasmid and 30 ng of Renilla firefly control plasmid 
(pRL-SV40; Promega) using the Lipofectamine STEM Regenet (Thermo Fisher) at a 1:3 ratio (DNA:μL 
Reagent). Cells were cultured for an additional 72 hours prior to analyzing for luciferase expression using 
the Dual-Glo Luciferase Assay System (Promega). luc2 and Renilla expression was measured using a 
ClarioSTAR Plus plate reader (BMG LABTECH) and the relative luminescence units (RLU) were 
calculated for each well by dividing the luminescence for luc2 by the Renilla control. Sample RLU values 
were additionally normalized to the background expression of the empty pGL4.23 vector. Experiments 
were performed for 6 unique donor lines with the average RLU values of 3 wells per donor per plasmid 
being used as a biological replicate.  
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CRISPRi cloning and gene expression 
gRNAs targeting RE1 and RE2 were designed using GT-Scan (207) for CRISPRi experiments. 
An initial 4 gRNAs were selected for each regulatory element that were positioned at roughly even 
spacing along the length of each element. Additional 2 non-targeting gRNAs were used as controls. 
gRNAs were cloned into pLV-U6-C-UbC-DsRed-P2A-Bsr (https://www.addgene.org/83919/) for gene 
expression experiments or Lenti-(BB)-EF1a-KRAB-dCas9-P2A-EGFP 
(https://www.addgene.org/118156/) for high content imaging experiments using BsmbI restriction sites. 
For gene expression experiments, an additional Lenti-dCas9-KRAB-blast 
(https://www.addgene.org/89567/) vector was used for dCas9-KRAB expression. Lentiviruses for each 
plasmid were generated using the psPax2 (https://www.addgene.org/12260/) packaging plasmid and 
pMD2.G (https://www.addgene.org/12259/) envelope plasmid as described previously (189). 293T cells 
were cultured directly in phNPC proliferation media for 48 hours after transfection using TransIT-LT1 
Transfection Reagent (Mirus Bio). The viral supernatant was then harvested, purified by syringe filtering, 
and frozen at -80C for direct use in subsequent experiments. Viral titers were calculated using the qPCR 
Lentivirus Titer Kit (Applied Biological Materials).  
 
An initial screen of the 8 generated gRNAs viruses was performed to identify gRNAs with the 
highest potential effects on FOXO3 expression. phNPCs were plated in 24 well plates at 80,000 cells per 
well. The following day, cells were infected with viruses for Lenti-dCas9-KRAB-blast and pLV-U6-C-
UbC-DsRed-P2A-Bsr containing the targeting gRNAs at a calculated MOI of 2 for each virus. Plates 
were then spun in an incubated centrifuge at 37°C for 1 hour to improve transduction efficiency (208) and 
media was fully replaced after 4 hours. phNPCs were cultured for an additional 5 days after infection 
prior to RNA extraction. RNA purification was performed using the Direct-Zol RNA Microprep Kit 
(Zymo Research) and cDNA from 200ng of purified RNA was generated using the iScript cDNA 
Synthesis Kit (Bio-Rad). Gene expression was then measured by qPCR using the SsoAdvanced Universal 
SYBR Green Supermix (Bio-Rad) and a QuantStudio 5 Real-Time PCR System (Thermo Fisher). Gene 
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expression values were normalized to the expression of the ACTB (Beta-actin) gene. Gene expression 
values for each targeting gRNA were compared to the non-targeting control.  Primers used for qPCR are 
as follows: ACTB; 5’-CATGTACGTTGCTATCCAGGC-3’ (Fwd), ACTB; 5’-
CTCCTTAATGTCACGCACGAT-3’ (Rev); FOXO3; 5’-CGGACAAACGGCTCACTCT-3’ (Fwd), 
FOXO3; 5’-GGACCCGCATGAATCGACTAT-3’ (Rev). From our initial screen, the 2 gRNAs out of 4 
per regulatory elements with the highest impact on gene expression were used for downstream analysis. 
qPCR experiments for each individual virus or a combination of 2 viruses were repeated for 5-6 unique 
phNPC donor lines with the average expression of 3 wells per donor per gRNA combination considered a 
biological replicate. All gRNAs sequences tested are listed below with the ones used for statistical 
analyses and high content screening in bold. 
 
Name Position Strand Sequence (5’-3’) 
Control-1 NA NA GAACCTCCCCGAATATCTGG 
Control-2 NA NA GTATTACTGATATTGGTGGG 
FOXO3-RE1-393 chr6:108,910,393 + AAATAAAGAAAAAATCTAAG 
FOXO3-RE1-513 chr6:108,910,513 - GGTCAAGACTCCCAGCTCCG 
FOXO3-RE1-919 chr6:108,909,919  - CCAGCCTACTATATTCTAGG 
FOXO3-RE1-940 chr6:108,909,940 + GATCCTTATGGGAAATTTAG 
FOXO3-RE2-76 chr6:108,927,356 + GGAATTCTGTACAGTATGCTGGG 
FOXO3-RE2-259 chr6:108,927,539 + CCTTCCCAAGGGCGGTTTGTTGG 
FOXO3-RE2-263 chr6:108,927,543 - CTTGCCAACAAACCGCCCTTGGG 
FOXO3-RE2-474 chr6:108,927,754 + TATGATTAAGGCTTATCTACAGG 
 
Immunocytochemistry and high content imaging 
High content screening of phNPC proliferation and differentiation was performed by 
immunocytochemistry followed by high content imaging. phNPCs were plated in 96 well plates at 20,000 
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cells per well. The following day, cells were infected with gRNA/dCas9-KRAB containing viruses 
generated from the Lenti-(BB)-EF1a-KRAB-dCas9-P2A-EGFP vector as described above. gRNA pairs or 
quadruplets were used in each tested condition with a summed total viral MOI of 4 for each well. 
Following viral infection, cells were proliferated for 5 days or differentiated for 10 days by removing 
FGF/EGF/PDGF/LIF growth factors and replacing them with BDNF/NT3 in differentiation media, as 
described previously (86, 188, 189). Cells were then fixed using 4% paraformaldehyde, permeabilized 
with 0.1% Triton X-100/PBS, blocked with 10% normal goat serum in 0.1% Triton X-100/PBS, and 
subjected to immunocytochemistry. Cells were treated with the following primary antibodies in 0.02% 
Tween-20/PBS overnight at 4oC: Tuj1 (1:1000, Biolegend, CA# MMS-435P), Sox2 (1:500, Thermo 
Fisher, CA# 14-9811-82), Ki67 (1:1000, Thermo Fisher, CA# 14-5698-82). Cells were then treated with 
the following secondary antibodies for 1 hour at RT at 1:1000 dilution: Goat anti-RT AF647 (Thermo 
Fisher, CA#: A-21247), Goat anti-MS AF568 (Thermo Fisher, CA#: A-11031). DAPI was then added for 
10 minutes to label cell nuclei prior to imaging.  
 
Plates were imaged using a Nikon Ti2 fluorescent microscope using a 10x objective (~0.6 
μm/pixel resolution). 3-4 fields of view were acquired for each well. Fluorescent images were then 
analyzed using custom CellProfiler pipelines. Briefly, cell nuclei were segmented using otsu thresholding 
and co-localized marker protein labeling was measured. Cell-types were classified as positive if their 
average intensity nuclear intensity values were 5 median deviations above background. Wells containing 
excessive debris or cell loss were removed from analysis. The average cell counts from 4-6 wells per 
donor per condition were treated as a biological replicate.  
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CHAPTER 5: CHARACTERIZING STRUCTURES OF THE DEVELOPING CORTEX AT 
CELLULAR RESOLUTION 
5.1 Introduction 
Cortical development is an intricate process that results in billions of interconnected neurons that 
make up the adult human brain. Expansion of the neocortex during evolution is thought to have driven the 
advancement of human cognitive and social abilities that distinguishes us from other mammalian species 
(209, 210). However, these evolutionary changes in brain complexity have also been associated with 
certain psychiatric disorders, such as autism (211, 212) and schizophrenia (213, 214) . Cortical structure 
is shaped by the proliferation and differentiation of neural progenitor cells during the period of 
neurogenesis of fetal brain development (215). As more progenitor cell divisions occur, more neurons are 
eventually produced, leading to tangential expansion and eventual cortical folding in the primate brain 
(215, 216). However, dissecting the molecular pathways that determine cortical cell-type behaviour is 
challenging due to the difficulties in accessing primary human brain tissue during these stages of 
development. Instead, we largely rely on modeling these processes using cultured human neural stem 
cells or animal models. Using these models in combination with newly developed tissue clearing 
methods, we now have the tools to profile brain structure changes at the cellular level across multiple 
developmental stages.  
 
Many of the cell-types and developmental features of the human fetal brain are conserved within 
the rodent brain (217). For example, the mouse cortex contains a ventricular zone, subventricular zone, 
and a cortical plate that matures into a 6 layered cortex, as in the human. These zones contain radial glial 
cells, intermediate progenitor cells, and neurons characterized by expression of the same laminae-specific 
protein markers, many of which are conserved between mouse and human. Mouse models are amenable 
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to genetic engineering at germline, allowing the effects of genetic variation to be studied at the 
organismal level and consequently, across functionally defined cortical regions. In addition, the genetic 
effects on behavioral manifestations can be studied during postnatal stages. Therefore, animal models can 
be important tools for studying cortical development, particularly for analyzing the effects of single gene 
mutations, as was shown with the Top1 and Nf1 mouse models in Chapter 2.  
 
Brain organoids are alternative systems for studying the structural phenotypes present during 
cortical development within a human model system (218). Organoid models are derived from human 
pluripotent stem cells which, upon molecular reprogramming, self-assemble to form 3 dimensional 
structures that mimic those of the fetal cortex. Brain organoids can therefore be derived from individuals 
diagnosed with neurodevelopmental disorders to study the underlying disease pathology during the early 
stages of brain development. Many, but not all, cell-types in the human fetal cortex can be modeled using 
organoid systems. Cell-types such as outer radial glia, which are underrepresented in the mouse cortex, 
are produced during differentiation while endothelial cells and microglia cannot be derived by standard 
differentiation to ectodermal fate. Brain organoids are also amenable to high-throughput screening as in 
standard 2D culture systems with added opportunity to investigate 3D cortical organization. Organoid 
models are therefore well suited for studying the structural deficits caused by human-specific, disease 
relevant mutations at greater scale than animal models.  
 
In Chapter 2, I showed how tissue clearing methods and the NuMorph software package can be 
used to perform quantitative analysis of cortical structure at cellular resolution in the adult mouse. 
Compared to the adult mouse cortex, the fetal cortex, either in the embryonic mouse or modeled as a 
human brain organoid, has significantly different properties. In particular, embryonic tissues are much 
smaller compared to their adult counterparts but they are noticeably more cell-dense as limited branching 
and axon extension of immature neurons reduces the amount of separation between cells. Here, I explore 
whether tissue clearing and quantitative analysis using NuMorph can be used to characterize the cellular 
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components of brain structure during cortical development. These results are meant to guide future 
experimental designs and touch on important considerations for analyzing embryonic tissues compared to 
adult brain samples. 
 
5.2 Results 
Tissue Clearing of the Embryonic Mouse Cortex 
First, I tested whether tissue clearing was able to resolve cells within the mouse embryonic cortex 
while maintaining structural integrity. Here I performed whole-mount iDISCO+ clearing of E14.5 wild 
type embryonic mice. To identify regions within the dorsal telencephalon, I performed immunolabeling 
using Pax6 and Tbr2 antibodies to delineate radial glia in the ventricular zone and intermediate progenitor 
cells in the subventricular zone, respectively. I also included an antibody specific for phospho-Histone 3 
(pH3), which marks cells undergoing mitosis, as well as ToPro3 to label all cell nuclei. Cleared embryos 
were then mounted without agarose embedding and imaged using light-sheet microscopy. My results 
show that iDISCO+ can achieve excellent clearing of embryonic samples while maintaining tissue 
integrity. Specific immunolabeling was also achieved for Pax6, Tbr2, and pH3 (Figure 23). However, 
because of the increased cell density in the embryonic cortex, identification of individual nuclei was 
difficult, even at the highest resolution and light-sheet NA that was tested (12x zoom,  0.48x0.48x2.5 
μm/voxel, 0.15NA). Furthermore, due to the lack of perfusion prior to tissue fixation, there was 
significantly greater autofluorescence in green to yellow spectral wavelengths from tissue vasculature, 
compared to previously imaged adult brain samples. These results suggest more advanced computational 
methods or higher resolution imaging will be required to accurately quantify cell nuclei in the embryonic 
mouse cortex. Additionally, greater care is to be taken with embryonic samples, which includes fully 
eliminating residual blood prior to tissue fixation and careful handling during the clearing procedure and 
sample mounting. 
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Clearing and Quantitative Analysis of Human Cortical Organoids 
Next, we tested whether tissue clearing could be used to quantify cell-types and delineate cortical 
zones within a brain organoid model. Here we induced cortical patterning of H9 embryonic stem cells 
(ESC) or PGP1 induced pluripotent stem cells (iPSCs) using dual SMAD inhibition (219). We followed a 
protocol that was previously shown to generate highly structured neuroepithelial buds following Matrigel 
embedding as well as long term preservation of cell viability by culturing in spinning bioreactors to 
increase oxygen and nutrient diffusion (220, 221). Using this protocol, we were able to maintain cerebral 
organoids in culture for up to 84 day. Organoids were harvested on day 30 (D30) or day 84 (D84) and 
cleared using iDISCO+ using 2 sets of antibodies. The first set used on D30 organoids were antibodies for 
SOX2 and Tuj1, which are markers of neural progenitors and immature neurons, respectively. These 2 
markers can therefore be used to mark regions that mimic the germinal zone and cortical plate of the 
developing human cortex. Similarly as in embryonic mouse, the imaging resolution was not sufficient to 
separate individual cell nuclei in the D30 cortical organoids. However, basic thresholding on SOX2 and 
Tuj1 labeling intensity can still identify progenitor or neuron rich regions, from which germinal zone and 
cortical plate volumes can be quantified (Figure 24). This analysis procedure can therefore be used to 
measure the balance between neural progenitor proliferation and differentiation during cortical organoid 
development. 
 
Finally, we tested for the presence of neuronal cell-types within tissue cleared D84 organoids. 
Using antibodies for CTIP2, a marker for lower layer neurons, and CUX1, a marker for upper layer 
neurons, we detected neuronal cell-types localizing predominantly on the outer edges of neuroepithelial 
buds that represent the cortical plate. As CTIP2/CUX1 labeling was not as dense as the previous 
SOX2/Tuj1 labeling, we used NuMorph, developed in Chapter 2, to quantify the number of upper and 
lower neurons within the D84 organoids. Specifically, we applied the 3D-Unet directly on each nuclear 
marker and refined the detection results using the supervised support vector machine classifier to reduce 
false positive classifications. Our results show a significant number of both cell-types being present at the 
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D84 time point of organoid differentiation (Figure 25). This demonstrates that cell-types within dense 
cortical organoid tissues can still be quantified without detecting all cell nuclei using NuMorph. 
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Figure 23. Tissue Clearing of Embryonic Mouse Cortex. 
A-D. Representative optical sections of E14.5 mouse cortex imaged using light-sheet microscopy after 
iDISCO+ clearing. Tbr2 (A) is a marker for intermediate progenitor cells, pH3 (B) is a marker for 
dividing cells, and ToPro (C) stains all cell nuclei. 
E. 3D representation of Pax6 labeling in the cleared E14.5 mouse embryo. Pax6 is a marker for dorsal 
telencephalic progenitors that localize in the cortical ventricular zone (VZ). 
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Figure 24. Segmentation of D30 Organoid Structure Volumes 
A-B. Representative images of D30 cortical brain organoids derived from H9 embryonic stem cells. 
Organoids were differentiated for 30 days prior to fixation and clearing using iDISCO+. Sox2 (A) marks 
neural progenitor cells found in the germinal zone of the developing human cortex. Tuj1 (B) marks 
nascent neurons found in the cortical plate. Basic thresholding of Sox2/Tuj1 labeling intensity was 
performed in Imaris to delineate structure volumes. Scale bar: 500 μm. 
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Figure 25. Neuronal Cell-type Quantification in D84 Organoids.    
A-B. Representative images of cortical brain organoids derived from PGP1 iPSCs with point cloud 
visualizations generated using NuMoprh.. Organoids were differentiated for 84 days prior to fixation and 
clearing using iDISCO+. Ctip2 (A) marks lower layer neurons and Cux1 (B) upper layer neurons. Scale 
bar: 500 μm. 
C. Total cell counts detected using NuMorph for the organoid in A-B.  
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5.3 Discussion 
Cellular processes during fetal brain development shape the structure of the human cortex and can 
be dysregulated in disease. Here I demonstrated how tissue clearing can be applied to study the changes in 
cellular organization during cortical development using animal and human brain organoid models. 3D 
imaging and subsequent analysis of cleared tissue can be used to quantify cortical cell-types while 
preserving their spatial location within tissue regions. This can serve as an orthogonal method to single 
cell sequencing approaches that also measure cell-type numbers but traditionally miss spatial information 
(124, 222). By sampling multiple developmental timepoints, spatial trajectories mapping the progression 
of progenitor cells to established cortical units, akin to single-cell trajectory analyses (223, 224), can also 
be quantified using 3D imaging approaches. Differences in developmental trajectories within models of 
neurodevelopmental disorders can be used to infer critical time periods and cortical regions associated 
with disease progression. 
 
A key limitation of these analyses was the inability to resolve individual nuclei in densely packed 
embryonic tissues within both the mouse cortex and cortical organoids. While individual protein markers 
that localize in the nucleus can still be quantified using tools such as NuMorph, the proportion of each 
cell-type relative to all cells cannot be calculated. More advanced machine learning models trained on 
annotations from these tissue types could potentially improve cell quantification accuracy. Tools such as 
Segmentor, discussed in Chapter 3 of this work, can accelerate the rate of training data acquisition. A 
class of deep learning models performing axial deconvolution can also be implemented to better resolve 
cell-dense tissues (134). Alternatively, imaging systems with higher resolution capabilities can be used 
instead of the current light-sheet system, although this could potentially lower throughput and greatly 
increase data sizes. In summary, while characterization of certain sparsely labeled cell-types is possible 
using the current set of imaging and analysis tools, additional work is needed to reach the same level of 
cellular phenotyping as was done in our previous study in the adult mouse brain.  
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5.4 Methods 
Tissue Clearing of Embryonic Samples 
E14.5 wild-type embryonic mice were dissected and postfixed in 4% paraformaldehyde 
overnight. Samples were then subsequently processed by iDISCO+ tissue clearing as described in Chapter 
2 with slight modifications. Primary and secondary incubations were performed for 3 days each. The 
following primary antibodies at the indicated dilutions were used: Pax6 (1:300, Biolegend, CA# 901301), 
Tbr2 (1:300, Thermo Fisher, CA# 14-4875-82), phospho-Histone 3 (1:300, Santa Cruz, sc-374669 AF 
488). The following secondary antibodies at the indicated dilutions were used: Goat anti-Rat AF 568 
(1:500, Thermo Fisher, #A-11077), Goat anti-Rabbit AF800 plus (1:200, Thermo Fisher, A32735). 
ToPro3+ was used for staining cell nuclei.  
 
Brain Organoid Differentiation and Clearing 
Cerebral organoids were generated according to previously published protocols (220, 221). 
Briefly, H9 human ES cells or PGP1 (Personal Genome Project 1) human iPS cells were dissociated into 
single cells using accutase and plated into 96-well V-bottom plates. Plated cells were cultured in forebrain 
first media as described in the referenced protocols for 7 days prior to matrigel embedding. Embedded 
embryoid bodies were then cultured for an additional 7 days in forebrain second media. Organoids were 
then gently dissociated from the matrigel embedding and placed in a SpinΩ bioreactor for long-term 
culture in forebrain third media. At Day 70, forebrain third media was replaced with neuronal maturation 
media. Organoids were fixed at Day 30 or Day 84 in 4% paraformaldehyde for 1-2 hours at RT prior to 
tissue clearing using iDISCO+. Tissue clearing proceeded as described for embryonic mouse samples. 
Primary and secondary incubations were performed for 1 days each. Organoids were embedded in 1% 
agarose following secondary antibody incubation and prior to the final methanol dehydration steps. The 
following antibodies at the indicated dilutions were used: Tuj1 (1:1000, Biolegend, CA# MMS-435P), 
Sox2 (1:500, Thermo Fisher, CA# 14-9811-82), Ctip2 (1:500, Abcam, ab18465), Cux1 (1:500, Abcam, 
ab140042). The following secondary antibodies at the indicated dilutions were used: Goat anti-Rat AF 
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568 (1:500, Thermo Fisher, #A-11077), Goat anti-Rabbit AF800 plus (1:200, Thermo Fisher, A32735). 
ToPro3+ was used for staining cell nuclei.  
 
Light-Sheet Imaging and Analysis 
Light sheet imaging was performed on the LaVision Ultramicroscope II using the 4x zoom setting 
and a 2.5 μm z step. Dynamic horizontal focusing using the contrast adaptive setting was incorporated to 
maintain axial resolution throughout the field of view. The final spatial resolution was 0.75x0.75x2.5 
μm/voxel. D84 organoids acquired across multiple tiles while D30 organoids were small enough to be 
imaged within a single tile. 
 
Images from Day 30 organoids were loaded into Imaris for analysis and rendering. Progenitor or 
neuron rich regions were segmented using the “Surfaces” tool by thresholding based on Sox2 or Tuj1 
labeling, respectively.  
 
Images for Day 84 organoids were processed and analyzed using NuMorph. Briefly, Ctip2 and 
Cux1 images were stitched individually without channel alignment as nuclei detection was not performed. 
Detection of Ctip2+ and Cux1+ nuclear labeling was then quantified by running 3D-Unet detection 
directly on these markers. A supervised SVM classifier was then generated for each marker using a 500 
patch training set. This classifier was then used to prune cells with low labeling intensity or background 
staining thereby reducing false positive classification.  
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CHAPTER 6: DISCUSSION 
In my graduate work, I developed a computational framework called NuMorph for end-to-end 
processing of tissue cleared mouse brain images in Chapter 2. NuMorph was used to identify significant 
cell-type differences across cortical regions in a Top1 cKO mouse model with large structure deficits and 
a Nf1 cKO model with more subtle effects that recapitulated structure changes seen in Neurofibromatosis 
Type 1 patients. In Chapter 3, I introduced a new computational tool called Segmentor, developed in 
collaboration with David Borland, to more rapidly generate 3D annotation data. In Chapter 4, I identified 
a potential mechanism that impacts cortical surface area and human intelligence through common genetic 
variation at the FOXO3 locus. In Chapter 5, I showcased how tissue clearing technologies can be applied 
to dissect 3D structural phenotypes present during cortical development at the cellular level in human and 
animal models. These studies have focused on the goal of mapping neurobiological pathways impacted by 
common and rare genetic variation that lead to changes in brain structure and risk for neuropsychiatric 
illness. The results of my work have led to different insights into the challenges and directions for future 
studies. 
 
6.1 Next generation tissue-clearing and imaging methods  
Over the last decade, the development of tissue clearing technologies have provided an 
opportunity to explore exciting new scientific directions and so far they have been applied for a number 
of different use-cases. These include measuring early gene activity (62), tracking cancer cell metastasis 
(225), analyzing axonal projections (93, 132), testing viral transduction efficiency (226), analyzing 
Alzheimer's plaque formation (102), and studying brain vasculature (75). In this work, our goal was to 
perform the simple task of counting cells and determine where cell counts differed between wild-type and 
a genetically modified mouse model. In practice, this seemingly basic task was much more challenging 
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due to the increased complexity of 3D imaging and analysis as well as the lack of computational tools that 
existed at the beginning of this work. NuMorph was developed to address some of these challenges and 
provide the scientific community with an easy-to-use tool to analyze the cellular organization within their 
own images. In the Top1 cKO model, we show that NuMorph can identify regional differences in cortical 
morphology, even in the presence of large overall deficits. Furthermore, by using resources made 
available by the Allen Institute, we identified interesting correlations between cell count differences in 
these regions and the expression of long genes known to be regulated by Top1. In the Nf1 cKO model, we 
showed that deletion of the Nf1 gene leads to changes in cortical thickness that recapitulate the 
phenotypes seen in patients with Neurofibromatosis type 1 and found that glia were the key cell-type 
driving these changes. Additionally, we identified significant areal differences in neuronal cell-type 
proportions across cortical regions that would otherwise be difficult to detect by tissue sectioning, further 
motivating a 3D, whole brain imaging approach. 
 
Many of the protein markers used in this work for cell-type classification were localized in the 
nucleus. Nuclear markers simplify the analysis procedure as they colocalize with DNA labeling and are 
relatively sparse. However, many of the canonical markers for distinguishing brain cell-types also localize 
in the cytoplasm and are much more difficult to disambiguate in densely packed tissues. Furthermore, the 
diffusion of antibodies specific for these markers can be limited by the increased number of 
physicochemical interactions. For example, antibodies for GFAP, a commonly used marker for astrocytes, 
are not able to penetrate into the cortex after iDISCO+, which required us to use 2D 
immunohistochemistry for astrocyte quantification in Chapter 2. Recent updates in tissue clearing 
protocols have shown improvements in antibody penetration without the need for additional 
instrumentation (78, 81). The next challenge is developing computational tools capable of segmenting 
entire cellular bodies that are labeled. Stochastic, multi-color labeling methods such as Brainbow can 
provide enough spectral contrast to visually distinguish complex neuronal networks (227). Additional 
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morphological features from whole cell labeling, such as cell volume, surface area, and branching, can 
also provide a more in-depth characterization of these cell-types beyond protein marker expression. 
 
In addition to protein marker expression, the molecular identity of a cell can also be defined by 
the information contained in its expressed RNA. Targeting RNA is an important alternative for cellular 
labeling when specific antibodies do not exist or for profiling untranslated molecules. Tissue clearing 
techniques, particularly hydrogels-based methods, have shown to be compatible for targeting specific 
RNA transcripts (57, 93, 228–230). However, RNA detection by in situ hybridization typically produces a 
weaker signal compared to immunolabeling and thus far, has mostly been demonstrated in thick mouse 
brain sections (231). Still, there is a great opportunity for not just detecting the presence of specific RNA 
targets, but also directly sequencing all RNA transcripts within intact tissues. Fluorescent in situ 
sequencing (FISSEQ) performs SOLiD sequencing of amplified cDNA fragments generated from fixed 
RNA transcripts within intact cells and tissues for thousands of RNA molecules (232). An extension of 
this approach called expansion sequencing (ExSeq) adapts expansion microscopy to increase spatial 
resolution for detecting RNA localization (233). Although these results were obtained in thin 2D sections, 
they provide a framework to achieve highly multiplexed RNA libraries within intact cleared tissues in 
future work. On-tissue sequencing technologies would provide a much deeper characterization of cell-
types as cells would be defined by their full spatial and transcriptomic profile instead of just a few marker 
genes. The ability to capture the complete transcriptome of each cell within a whole brain in its native 
spatial location would be a truly remarkable advance in tissue clearing technologies.  
 
Regardless of clearing method, having an imaging system that can acquire 3D images at a 
reasonable rate that can resolve the molecular target is critical for performing quantitative analysis of 
cleared intact tissues. Throughout this work, we used a commercially available light-sheet microscope 
that could resolve all cell nuclei within the adult mouse cortex but was insufficient for individual nuclei 
segmentation in the embryonic brain. The resolution of light-sheet microscopy is often limited by the 
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axial resolution that can be achieved, which is determined by the thickness of the light-sheet that is 
produced. Recent developments in the design of next-generation light-sheet microscopes have improved 
our ability to image large intact volumes in greater detail. Improvements in axially sweeping 
methodology have recently enabled isotropic imaging with submicron resolution (234). Lattice light sheet 
microscopy uses structured illumination to produce ultra-thin light sheets and was used in combination 
with tissue expansion to map presynaptic sites throughout the entire Drosophila brain (76). In addition to 
light-sheet microscopy, automated block-face imaging methods that integrate tissue sectioning with 
fluorescence microscopy have been used for whole brain connectomic profiling (68, 235, 236). Many, if 
not all, of the systems previously mentioned are not commercially available and still require custom 
assembly. In addition, a natural consequence of increased resolution is a heavier data burden that can be 
difficult to manage when imaging multiple samples. Careful consideration is to be taken to find the 
correct balance between resolution, imaging rate, and optical configuration that is needed to answer a 
specific scientific question. The parameters determined prior to imaging greatly influence the types of 
data resources and computational steps that are required during downstream image analysis.  
 
6.2 Improving deep learning models for analyzing cleared tissue images 
To quantify cells within 3D images, the NuMorph pipeline relies on a 3D-UNet deep learning 
architecture to achieve accurate detection of cell nuclei. Deep-learning-based models have shown great 
potential to solve difficult problems in image analysis (79, 237). Models are typically deployed on a 
graphical processing unit (GPU) making analysis of large 3D image datasets tractable. However, deep 
learning models depend on sufficient training data to perform well. For training the 3D-Unet, a significant 
time investment was made in acquiring annotations for tens of thousands of nuclei before performance 
improvements over non-learning based methods were reached. Even though the images patches selected 
were from different parts of the cortex, they did not contain nuclei from other brain regions. Furthermore, 
these cell nuclei were all cleared using the same tissue clearing method (iDISCO+) and imaged with the 
same optical configurations. Hyperparameters during model training were optimized to achieve the most 
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accurate detection results for specifically our datasets. All of this is to say that an extremely large amount 
of annotation data is required to train and evaluate a deep learning model that is both accurate and 
generalizable across multiple imaging conditions. To accelerate the rate of training data acquisition, we 
developed Segmentor in Chapter 3 to incorporate 3D visualization during the annotation processes that 
decreased labeling times while retaining high accuracy. Additional strategies applied by others in the field 
have included pre-annotating images using an iteratively updated segmentation model (238) and crowd-
sourcing the labeling process as a gamified task through citizen science (239). In addition, an updated 
UNet architecture called nnU-Net was recently developed that automatically configures itself with an 
optimal set of hyperparameters throughout model training (240). Implementing these improvements can 
reduce the time to a deep learning framework that can achieve accurate cell counting results and also 
generalizes across multiple brain regions.   
 
In addition to cell counting, deep learning has been used for several other tasks relevant for 
cleared image analysis, including specific applications in neuroscience. For example, a 3D-UNet 
architecture was also used to map axonal projections throughout the entire mouse brain after clearing 
(132) and tracking tumor micrometastases throughout the entire mouse body (225). Segmentation of 
neuronal processes using neural networks can also be used to characterize cell morphology (241). Deep 
learning tools can also be deployed prior to analysis to augment the imaging procedure or improve image 
quality (242, 243). Content-aware image restoration (CARE) is a network that can enhance image low 
signal-to-noise or compensate for a lack of resolution during imaging (134). A similar concept that boosts 
light-sheet image resolution can be used to reduce imaging times (244). Therefore, deep learning can be 
applied both to streamline the process of image acquisition and extract new, meaningful information from 
the acquired data. These computational tools hold immense potential to uncover novel cellular phenotypes 
in cleared tissue images.  
 
 112 
6.3 Measuring brain structure changes across developmental time 
Genetic risk for psychiatric disorders such as ASD and SCZ is often associated with 
dysregulation of neurodevelopmental processes. Molecular factors involved in cortical neurogenesis play 
a prominent role in shaping cytoarchitecture and functional connectivity in the adult cortex. As in the 
adult brain, measuring cellular organization during human cortical development is challenging due to the 
limited access to human fetal tissue. Furthermore, psychiatric disorders are diagnosed during postnatal 
stages and because almost all genetic risk factors are not fully penetrant, there is no guarantee that an 
individual with a set of risk alleles will have a particular clinical diagnosis. In Chapter 5, I explored 
whether tissue clearing can be used to study different models of cortical development such as the 
embryonic mouse cortex and human cortical organoids. Limitations in imaging resolution prevented us 
from fully quantifying all cell nuclei in these models, as was done in the adult mouse cortex. However, by 
implementing new clearing strategies, such as tissue expansion, or by using microscopes with higher 
resolution capabilities, I’m confident this goal can be achieved making this a worthwhile direction for 
future studies.  
 
In the context of neurodevelopmental disorders, there are many unanswered questions that tissue 
clearing technologies are uniquely positioned to solve. Take for example, the brain overgrowth phenotype 
seen in ASD patients with CHD8 mutations. Loss-of-function mutations in CHD8 are commonly 
associated with increased brain size and head circumference. Several groups have generated heterozygous 
null Chd8 mouse models to study the biological mechanisms leading to ASD risk and each of these 
models also exhibit brain overgrowth as measured by brain weight or MRI imaging (245–248). An 
increase in proliferation and the number of apical progenitors was also observed by 
immunohistochemistry in some studies (246) but not in others (245). Recent efforts to quantify neurons 
using 2D stereology detected no significant differences within a Chd8 haploinsufficient model with 
known overgrowth (249). Therefore, it is still unknown what cell-types make up the enlarged Chd8 cortex 
and how the developmental trajectories of cortical progenitors may be modulated in the Chd8 model. As 
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demonstrated with the Top1 and Nf1 models, cleared image analysis using the tools currently available 
could be used to image the adult Chd8 cortex, answering the first of these questions. The ability to clear 
and analyze the Chd8 embryonic cortex would then identify the critical developmental time periods and 
cortical regions where the loss of Chd8 is exhibiting the strongest effect. The resulting effects on 
postnatal brain morphology can then be related to structural changes in ASD patients with CHD8 
mutations. These findings would be a major contribution to our understanding of ASD etiology.  
 
iPSC-derived brain organoids provide a human specific model to study molecular changes in 3D 
context. By using stem cells derived from patients diagnosed with disorder or by genetically engineering 
specific mutations in control lines, the genetic effects on developmental brain structure can be studied in a 
dish. Cortical organoids contain many of the cell-types present in the fetal brain and similarly develop in 
an “inside-out” pattern where the earliest produced neurons are found in the deeper cortical laminae. 
However, several limitations have been noted with organoid models. For example, organoids lack some 
of the key cell-types found in the fetal cortex, such endothelial cells that make up the brain vasculature. 
Brain organoids do not mature at the same rate as the fetal brain and differentiation protocols can be 
difficult to reproduce across different stem cell lines and over long term culture (250). As many of the 
genetic components that influence disease risk are found in human-specific regulatory elements, 
improving the fidelity of the models is highly important. By modulating the effects of these regulatory 
elements within an organoids system, we can map the direct impact on structural phenotypes by tissue 
clearing. This can provide some insight into the cellular mechanisms that influence structure of the 
developing human cortex, which otherwise would not be possible using current imaging modalities that 
lack cell resolution capabilities.  
 
6.4 Scaling up functional screening in model systems  
In Chapter 4, I demonstrated how genetic variation in the FOXO3 locus can modulate 
neurogenesis and,  by doing so, influence adult brain size and cognitive ability. Characterizing this locus 
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involved mapping the complete pathway that linked the causal variant rs2802292 to a specific gene and 
cellular phenotype. However, complex traits such as human intelligence and risk for disease arise from a 
combination of a large number of small-effect genetic changes. Thus, the genetic influences of the 
FOXO3 locus explain only a small fraction of the heritability for a trait such as intelligence where 205 
associated loci were identified in the most recent GWAS (9). To meet the challenge of understanding 
these highly polygenic traits across multiple levels of biology, several new technologies that implement 
barcoded libraries have been developed to scale-up experimentation in functional genomics (251–253). 
 
Because of the correlation structure (or linkage disequilibrium) within the genome, it is difficult 
to identify the causal genetic variants within an associated locus. Experimentally validating the effects of 
specific alleles on downstream processes such enhancer activity or gene expression can require testing 
hundreds of polymorphisms within a locus. In Chapter 4, I prioritized a subset of variants in the FOXO3 
locus using statistical fine-mapping and quantified the effects of each individual variant within the 
subgroup on enhancer activity using a luciferase reporter assay. Massively Parallel Reporter Assays 
(MPRAs) are a high-throughput alternative to the luciferase assay that can test the activities of thousands 
of DNA elements simultaneously using sequencing-based quantification of reporter barcodes (254, 255). 
Engineered single base-pair changes within the DNA element can also be used to model allelic effects on 
enhancer function. When introduced into a cell model system, MPRAs can therefore be used to 
functionally characterize each genome-wide associated variant for a highly polygenic disease within a 
specific cell-type of interest. 
 
Functional variants are enriched near or within regulatory elements, like enhancers, in the non-
coding regions of the genome that are marked by increased chromatin accessibility. Linking multiple 
enhancers to specific target genes can be done by measuring their interaction with target gene promoters 
or colocalizing genetic risk loci with quantitative trait loci (QTL) data of gene expression. However, these 
approaches do not directly modulate the enhancer activity of putative regulatory elements to measure 
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resulting changes in gene expression and also require significant time and resources to perform in a cell-
type specific manner. In characterizing the FOXO3 locus, I was fortunate that data on chromatin 
accessibility specifically within human neural progenitor cells was already available from previous work 
in our lab. Using accessible chromatin peaks as putative enhancer regions, I targeted 2 regulatory 
elements using a CRISPRi approach to show that they influence FOXO3 gene expression via qPCR. To 
further scale this experimental design, genome-wide CRISPR perturbation assays at the single-cell level 
have been developed to test the effects of hundreds of regulatory elements on gene expression 
simultaneously (256–259). These assays work by linking each target gRNA to a specific barcode that is 
read during single cell sequencing of gene expression upon perturbation. Using a genome-wide approach 
allows not only mapping of enhancers to target genes, but also modeling of complex gene regulatory 
networks that determine cell states (257, 260). Altogether, the effects of multiple enhancer elements on 
the expression of multiple genes can be analyzed in a single assay, again in a cell-type specific manner.  
 
Following genomic perturbation, different cellular phenotypes can also be measured using high-
throughput screening approaches. In Chapter 4, our focus was on neural progenitor cell proliferation and 
differentiation as these processes were thought to influence cortical structure based on the radial unit 
hypothesis. However, other brain-related cellular phenotypes can be studied using the same perturbation 
assays as previously described. For example, a CRISPRi perturbation platform was recently used to 
screen for factors critical in determining neuronal cell survival and morphology (261). In a different 
study, a CRISPRa system that induced expression of thousands of transcription factors was used to 
identify key factors regulating neuronal fate specification (262). Screening approaches are readily coupled 
with optical imaging techniques such as fluorescent activated sorting (FACS) or fluorescence microscopy 
(263–265) to separate phenotypic groups or potentially uncover novel phenotypes. By implementing 
combinatorial screening in the embryonic mouse (266) or brain organoid models, gene expression 
networks directly influencing brain structure and risk for disease can be analyzed at single cell resolution 
within complex tissues.  
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6.5 Summary 
In my dissertation, I developed a computational tool called NuMorph that was used to quantify 
the effects of single gene mutations in Top1 and Nf1 on 3D cortical structure of the adult mouse at cellular 
resolution. I also identified mechanisms by which common genetic variation near the FOXO3 locus can 
influence cortical surface and cognitive abilities and demonstrated an approach to further study these 
effects on the fetal brain using human organoid systems. So much of the unknown surrounding genetic 
variation depends on biological context, which encompasses the cell-types, developmental periods, and 
tissues a particular genetic change can exert influence. Tissue clearing technologies provide only a piece 
of this context in the sense that only a subset of cell-types can be analyzed at a time but spatial context 
remains completely intact. Other genome-wide sequencing methods can profile hundreds of cell-types but 
typically sacrifice spatial information. New technological developments have opened an opportunity to 
extract even greater amounts of data from biological systems. Now the question is: can this push towards 
big data usher in a new era of therapeutic discovery? Neuropsychiatric disorders are incredibly complex 
due to their polygenic etiology, indicating that there is likely no silver bullet to cure these diseases. My 
belief is that with new biotechnologies and machine learning methods, we can learn the nuances within 
biological systems and use this knowledge to engineer better, multi-faceted treatments. I aim to develop 
the tools that will enable novel therapeutic discoveries for treating complex diseases in the next stage of 
my career.  
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